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Many drugs are available for the treatment of systemic or superficial mycoses, 
but only a limited number of them are effective antifungal drugs, devoid of 
toxic and undesirable side effects. Therefore there remains an urgent need for 
a new generation of antifungal agents. 
The present work concerns the synthesis, the antifungal activity and the 
biophysical characterization of a set of linear and cyclic peptides (AMT1, 
cyclo-AMT1, AMT2, cyclo-AMT2, AMT3, cyclo-AMT3) including 
aminoacids characteristic of membrane-active antimicrobial peptides (AMP). 
The peptides were tested against different yeast species, and displayed general 
antifungal activity, with a therapeutically promising antifungal specificity 
against Cryptococcus neoformans. 
To shed light on the role played by the membrane cell in the antifungal 
activity an extensive biophysical study was carried out using different 
spectroscopic techniques. Our structural investigation provides data to exclude 
the ability of the peptides to penetrate the membrane of the fungal cell, 
highlighting their attitude to interact with the external surface of the bilayer. 
Taken together our data support the hypothesis  that the membrane cell of the 
fungi may be an important platform for specific interactions of the synthesized 
peptides with more specific targets involved in the cell wall synthesis. 
 
Viral fusion glycoproteins present a membrane-proximal external region 
(MPER) which is usually rich in aromatic residues and presents a marked 
tendency to stably reside at the membrane interfaces, leading, through 
unknown mechanisms, to a destabilization of the bilayer structure. This step 
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has been proposed to be fundamental for the fusion process between target 
membrane and viral envelope. In present work, we investigate the interaction 
between an octapeptide (C8) deriving from the MPER domain of gp36 of 
Feline Immunodeficiency Virus and different membrane models by combining 
experimental results obtained by Nuclear Magnetic Resonance, Electron Spin 
Resonance, Circular Dichroism and Fluorescence Spectroscopy with 
Molecular Dynamics simulations. Our data indicate that C8 binds to the lipid 
bilayer adsorbing onto the membrane surface without deep penetration. As a 
consequence of this interaction, the bilayer thickness decreases. The 
association of the peptide with the lipid membrane is driven by hydrogen 
bonds as well as hydrophobic interactions that the Trp side chains form with 
the lipid headgroups. Notably these interactions may be the key to interpret at 
molecular level the function played by Trp residues in all the fragments of 







Fungal infections are a persistent major health problem, especially for 
immunocompromised patients. Invasive fungal infections can be life-
threatening for neonates, cancer patients receiving chemotherapy, organ 
transplant recipients and patients with acquired immunodeficiency syndrome 
(AIDS). Many fungal infections are caused by opportunistic pathogens that 
may be endogenous or acquired from the environment, including Candida, 
Cryptococcus, and Aspergillus. Cryptococcosis, which is caused by the 
encapsulated fungus Cryptococcus neoformans, has been lethal for HIV-
infected patients. Cryptococcus infects pulmonary organs and can disseminate 
widely, most commonly to the brain and skin.(1-3)  
Although it appears that many drugs are available for the treatment of 
systemic or superficial mycoses, there are only a limited number of effective 
antifungal drugs, many of them toxic and having undesirable side effects. 
Furthermore, resistance development and fungistatic r her than fungicidal 
activities represent limitations of current antifungal therapy.(4-6) Therefore 
there is an urgent need for a new generation of antifungal agents.(7) 
Cationic antimicrobial peptides (CAPs) have been found in almost all species 
of eukaryotic organisms and are recognized as the evolutionarily conserved 
components of their innate immune system that defen the host against 
microbes through membrane or metabolic disruption.(8) A distinguishable 
advantage of CAPs over conventional antibiotics is that they do not provoke 
immune responses.(9) Regardless of their origin and biological efficacy, CAPs 
share common features. They are short peptides (usually between 3-50 amino 
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acid residues), which include a large content of basic mino acids and a global 
distribution of hydrophobic and hydrophilic residues. Due to the high 
frequency of amino acid residues, such as R and K in their sequences, they 
carry an overall positive charge in the physiological pH range, which is of 
great importance for their interactions with the negative charges of bacterial 
cell membranes.(8) CAPs adopt an amphipathic conformation at polar-
nonpolar interfaces with a hydrophobic domain consisting of nonpolar amino 
acid residues on one side and polar or charged resiu  on the opposite. 
Because of these physicochemical characteristics, CAPs have a tendency to 
accumulate on the negatively charged microbial surfaces and membranes. 
Electrostatic interactions cause the accumulation of the cationic peptides at the 
negatively charged bacterial membrane, and hydrophobic interactions drive 
their insertion into the lipid bilayer.(10) 
Each CAP has a unique pattern of activity against a variety of Gram-positive 
and Gram-negative bacteria, yeasts, fungi and viruses.(11) While the 
antimicrobial peptide cecropin A is only active against Gram-positive bacteria, 
(12) MG 2 and dermaseptin show activity against both types of bacteria as 
well as fungi,(13),(14) and the membrane-lytic peptide MEL attacks both 
prokaryotic and mammalian cells.(15) 
Small CAPs rich in particular amino acid residues, such as R, W, and P have 
gained high interest as lead compounds(16-20). They are usually found as 
small antimicrobial motifs of much larger natural compounds.(21) The 
mechanisms of interaction of small and conformationally constrained peptides 
with cellular membranes, as well as the key factors hat provide bacterial 
specificity for these peptides, are much less well understood.(22) The 
mechanisms of action for antimicrobial peptides are not completely 
understood, but in most cases their biological effects are believed to involve 
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membrane disruption of the target cells.(21, 23-30) The proposed mechanism 
requires positively charged aminoacids to associate with negatively charged 
microbial membranes, causing the peptides to adopt a globally amphiphilic 
helical conformation at the membrane–water interfac. The ensuing membrane 
disruption can lead directly to cell lysis and death,(31, 32) or membrane 
permeabilization may allow peptide molecole to reach intracellular targets.(33, 
34) AMPs have gained attention as potential antifungal agents because their 
activity is not associated with resistance phenomena. Development of 
resistance by sensitive microbial strains against these AMPs is less probable, 
because AMPs exert their action by forming multimeric pores in the cell 
membranes, leading to cell lysis,(35) or interaction with the RNA or DNA 
after penetration into the cell.(36) Thus, among others, small RW-rich peptides 
with improved toxicity against bacteria are interesting candidates to study the 
structural motifs and forces responsible for selectivity and may pave the way 
to develop new therapeutics with potent activity against multi-resistant 
bacteria. 
Linear and cyclic RRWWRF, dubbed AMT1 and cyclo-AMT1, respectively 
(Figure 1), were recently indentified from a synthetic combinatorial library as 
new antimicrobial peptides,(37-39) exerting their action by inducing curvature 
strain, permeation or disintegration of the target membrane.(18, 37) Starting 
from AMT1 and cyclo-AMT1 sequence, we synthesised AMT2, cyclo-AMT2, 
AMT3 and cyclo- AMT3 (Figure 1) including one and two more His residues 
than the AMT1 analogues, respectively. The imidazole ring characteristic of 
His side chains was designed in the attempt to confer to AMT2, cyclo-AMT2, 
AMT3 and cyclo-AMT3 antifungal activity analogous to the imidazole ring of 
the azole antifungal compounds. The azole antifungal a ents, containing either 
two or three nitrogens in the azole ring, are currently the most widely used and 
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studied class of antifungal agents; they prevent syhesis of ergosterol, a major 
component of fungal plasma membranes, by inhibiting he cytochrome P450-
dependent enzyme 14a-sterol demethylase.(40-44) 
 
 
Figure 1 Chemical structures of AMT peptides. 
 
The aim of this work is to verify the antifungal activity of linear and cyclic 
peptides synthesized and to investigate the role of peptide-membrane 
interactions in antimicrobial activity. 
The antifungal activity was evalueted by in vitro test. 
Then, the ability of our peptides to interact with the surface of the fungal cell 
was monitored by fluorescence microscopy, using specifically labelled AMT 
peptide. 
To investigate the role of peptide-membrane interacions in the biological 
activity, biophysical investigation was carried out based on multiple analytical 
techniques including fluorescence spectroscopy, isothermal titration 








2.1 Peptide synthesis 
 
2.1.1 Solid-phase peptide synthesis and purification 
Peptides of Figure 1 were synthesized with a manual batch synthesizer 
(Agitatore orbitale Mod. KS 130 basic IKA, STEROGLASS, Perugia Italy) 
using a Teflon reactor (10mL), applying the Fmoc/tBu solid phase peptide 
synthesis (SPPS) procedure, together with the following side chain protecting 
groups: Arg, Pbf; His, Trt; Trp, Boc. (Chan, W.; White, P. Fmoc Solid Phase 
Peptide Synthesis; Oxford University Press:Oxford, 2000.) 
AMT1, AMT2 and AMT3 were synthesized with a Wang resin (0.6–1.0 
mmol/g, 0.2 g) that was swelled with N,N-dimethylformamide (DMF) (1 
mL/100 mg of resin) for 3 h before use. The Wang resin (0.6–1.0 mmol/g, 0.2 
g) was treated with N-Fmoc amino acid derivatives (fourfold excess), which 
were sequentially coupled to the growing peptide chain using O-benzotriazole-
N,N,N0 ,N0-tetramethyl-uronium-hexafluoro-phosphate (HBTU) (fourfold 
excess) in DMF and N,N-diisopropylethylamine (DIPEA) (eightfold excess). 
The coupling reaction time was 2 h. After deprotection of the last N-Fmoc 
group, the peptide resin was washed with methanol ad dried in vacuo to yield 
the protected peptide-bound Wang resin. The deprotected peptide was cleaved 
from the resin by treatment with trifluoroacetic acid 
(TFA)/H2O/phenol/ethanedithiol/thioanisole (reagent K) (82.5:5:5:2.5:5 v/v) 
at a ratio of 10 mL to 0.5 g of resin at room temperature for 3 h. After 
filtration of the exhausted resin, the solvent was concentrated in vacuo, and the 
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residue was triturated with ether. Cyclo-AMT2, cyclo-AMT1 and cyclo-
AMT3 were synthesized using a 2-chlorotrityl chloride resin. The first N-
Fmoc amino acid (0.6–1.2 equiv relative to the resin for 2-chlorotrityl resin) 
and DIPEA (4 equiv relative to amino acid) were dissolved in dry 
dichloromethane (DCM) (approx. 10 mL per gram of resin) containing, if 
necessary, a small amount of dry DMF (enough to facilit te dissolution of the 
acid). This was added to the resin and stirred for 30–120 min. After stirring, 
the resin was washed with 3X DCM/MeOH/DIPEA (17:2:1), 3 X DCM, 2X 
DMF and 2 X DCM. Other N-Fmoc amino acids (fourfold excess) were 
sequentially coupled to the growing peptide chain according to the Fmoc/tBu 
solid phase peptide synthesis (SPPS) procedure. The final cleavage with 
AcOH/MeOH/DCM (1:1:8) resulted in protected peptides. 
For fluorescence microscopy study we synthesized cyclo–AMT2 and cyclo–
AMT3 including Dap (l-diamino propionic acid) aminoacid in substitution of 
Trp. cyclo–AMT2 and cyclo–AMT3 with Dap aminoacid were synthesized 
according to the solid phase synthesis methods using Fmoc-Dap(NBD)-OH 
This was obtained by alkylating the free amino group f Nα-Fmoc, l-diamino 
propionic acid (Fmoc-Dap-OH) with NBD chloride. (45) 
 
2.1.2 General procedure for cyclization 
A solution of the linear protected peptide (0.03 mmol) in dry DMF (6.5 mL) 
was added at room temperature to a reaction flask containing a solution of N-
hydroxybenzotriazole (HOBt) (3 equiv, 12 mg, 0.09 mmol), HBTU (3 equiv, 
34 mg, 0.09 mmol) and DIPEA (5 equiv, 0.26 mL, 1.5 mmol) in dry DMF (1 
mL) using a syringe pump. The solution was added at rate of about 0.01 
mL/min. Once the addition was complete, the mixture was stirred for 24 h at 
room temperature. The reaction mixture was concentrated under reduced 
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pressure, and the residue was dissolved in ethyl acetate (AcOEt). The organic 
phase was washed twice with 5% aqueous sodium bicarbon te (NaHCO3), 
dried over sodium sulfate (Na2SO4), and filtered. The solvent was removed by 
reduced pressure, and the crude residue was purified by flash chromatography 
on silica gel (CHCl3/MeOH from 99:1 to 90:10) to yield the protected cyclic 
peptide as a glassy white solid. 
 
2.1.3 Side-chain deprotection 
The protected cyclopeptide (0.02 mmol) was treated with 10 mL of a solution 
of TFA/triisopropylsilane (TIS)/H2O 95:2.5:2.5 at room temperature. After 24 
h, the reaction mixture was evaporated in vacuo, and the residue was dissolved 
in 5 mL of 3 N aqueous hydrogen chloride (HCl). The aqueous phase was 
washed twice with diethyl ether (Et2O) and concentrated in vacuo, yielding 
the side chain-deprotected cyclopeptide as a hydrochloride salt (quant.). 
 
2.2  Peptide characterization 
2.2.1 Peptide purification 
All peptides were purified by preparative reversed phase high performance 
liquid chromatography (HPLC) using a Jupiter [Phenomenex, Anzola Emeilia 
(BO), Italy] C18 column (25 _ 4.6 cm, 5 l, 300 Å pore size). The column was 
perfused at a flow rate of 3 mL/min with a mobile phase containing solvent A 
(0.1% TFA in water). A linear gradient from 50% to 90% of solvent B (0.1% 
TFA in acetonitrile) for 40 min was adopted for peptide elution. The pure 
fraction was collected to yield a white powder after lyophilisation. After 
purification cyclo-AMT1, cyclo-AMT2 and cyclo-AMT3 were obtained in 
35%, 45% and 68% overall yield, respectively. The molecular weight of the 
compound was determined by mass spectral analysis. 
8 
 
2.2.2 Mass spectral analysis 
Peptide fragments were characterised using a Finniga  LCQDeca ion trap 
instrument equipped with an electrospray source (LCQ Deca Finnigan, San 
Jose, CA, USA). The samples were directly infused into the ESI source using 
a syringe pump set at a flow rate of 5 lL/min. The data were analysed with 
Xcalibur software. 
 
2.3 Antifungal tests  
 
2.3.1 Yeast isolates 
To verify the existence of antifungal activity the antifungal assays were 
performed using different yeast species. 
One-hundred and thirty-five yeast clinical isolates belonging to five Candida 
species (20 Candida albicans, 20 Candida glabrata, 20 Candida parapsilosis, 
20 Candida tropicalis and 20 Candida krusei) and 35 isolates of C. 
neoformans were tested. The Candida isolates were obtained from clinical 
specimens of blood, urine, vaginal fluid and sputum, whereas the C. 
neoformans isolates were all recovered from blood and cerebrospinal fluid 
specimens. We also included two reference C. neoformans strains, H99 and 
the acapsular ATCC 52817. Isolates were identified to the species level by 
standard methods and stored as glycerol stocks at -80 °C. Prior to testing, 
isolates were grown on Sabouraud dextrose agar (Kima, Padua, Italy) for 48 h 
at 30 °C. C. parapsilosis ATCC 22019 andC. krusei ATCC 6258 were used as 
quality control strain.( Clinical and Laboratory Standards Institute (CLSI), 
Reference Method for Broth Dilution Antifungal Susceptibility Testing of 
Yeasts; Approved Standard, 3rd ed.; CLSI document M27–A3. (ISBN 1-
56238-666-2) Clinical and Laboratory Standards Institute, 940 West Valley 
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Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2008). 
 
2.3.2 Susceptibility testing assays 
Susceptibility testing of the yeast isolates to the antifungals amphotericin B 
and fluconazole and to the six investigated peptides was performed by the 
broth microdilution method, as descrive in the Clinical and Laboratory 
Standards Institute (CLSI) M27-A3 document48 with a final inoculum 
concentration of 1.5 (±1.0) ×103 cells/mL in RPMI 1640 medium buffered to 
pH 7.0 with morpholinepropanesulphonic acid. Standard powders of 
amphotericin B and fluconazole were obtained from their respective 
manufacturers. For each drug, trays containing 0.1 mL of the serially diluted 
drug solution (2× final concentration) in each well were inoculated with 0.1 
mL of each diluted yeast inoculum suspension and then incubated for 48 h 
(Candida species isolates) or for 72 h (C. neoformans isolates) at 35 °C. The 
final concentrations of the standard antifungal drugs ranged from 0.03 to 16 
lg/mL for amphotericin B and from 0.125 to 64 lg/mL for fluconazole, while 
those of the peptides ranged from 1 to 512 lg/mL. The minimum inhibitory 
concentration (MIC) endpoint was defined as the lowest concentration of drug 
that produced a prominent decrease in turbidity (∼50% reduction in growth) 
compared with that of the drug-free growth control. 
 
2.3.3 In vitro test (fluorescence microscopy) 
Candida albicans strains ATCC 90028 and MYA-2876 were grown for 17 h 
in 10 ml YPD-broth at 28 °C to obtain mid-logarithmic phase organisms and 
washed three times, then diluted in 10 mM Tris, pH 7.4 to a concentration of 
1×107 cfu/ml. 100 µl samples of the C. albicans suspensions were incubated 
for 5 min on ice together with 1 µl of cyclo-AMT1 or cyclo-AMT3 (2 mg/ml). 
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The pellets were washed three times in 10 mM Tris, pH 7.4. Cell FIX (Becton 
Dickinson Catalogue No. 340181) was added (to a finl concentration of 4% 
formaldehyde) and the yeast cell pellets were incubated 15 min on ice and then 
45 min in room temperature. Ethanol washed glass cover slips were coated 
with 0.25 ml of poly-lysine (0.2 mg/ml dissolved inwater), dried and then 
washed with distilled water. The samples were adhered to the poly-lysine 
glasses for 30 min and mounted on microscope slides for visual inspection. A 
Nikon Eclipse TE300 inverted fluorescence microscope was used. 
 
2.4 Spectroscopic analysis 
 
2.4.1 Circular dichroism (CD) 
The samples for CD experiments in micelles of SDS were prepared by 
dissolving an appropriate amount of peptide (0,15 mM) in a SDS micelle 
solution (=0.08 mol kg-1). All CD spectra were recorded using a JASCO J810 
spectropolarimeter at room temperature and with a cell path length of 1 mm. 
CD spectra were acquired at 25 °C using a measurement range from 190 to 
260 nm, 1-nm band width, four accumulations, and 10-nm/min scanning 
speed. Spectra were corrected for solvent contribution. For an estimation of 
secondary structure content, CD spectra were analysed u ing the SELCONN 
algorithm from the DICHROWEB website.(46) 
 
2.4.2 Fluorescence titration measurements 
Fluorescence measurements were performed at 300 K using a LS 55 
Luminescence Spectrofluorimeter (Perkin Elmer). The excitation wavelength 
was 280 nm and emission spectra were recorded between 300 and 400 nm, at 
exitation slit width 5nm and emission slit width 2.5 nm, scan speed 50nm/min. 
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The titrations with SDS were performed by adding measured amounts of a 
phosphate buffer solution (pH 7;10 mM) containing the peptide (3×10−6 M) 
and the surfactant at a concentration well above the cmc to a weighed amount 
of a phosphate buffer solution of the peptide at the same concentration, 
initially put into the spectrofluorimetric cuvette. In this way, the surfactant 
concentration was progressively increased, while the peptide concentration 
remained constant during the whole titration. After each addition there was a 
10-min wait to ensure equilibrium had been reached. 
 
2.4.3 Isothermal Titration Calorimetry (ITC) 
Small unilamellar vesicles (SUVs) of average size z = 30 nm, composed of 
POPC/POPG (3:1, mol/mol) and of POPC/POPG/POPE (2/1/1; mol/mol/mol) 
were prepared as follows. The desired amount of POPC in chloroform was 
dried under a stream of nitrogen and then overnight under high vacuum. POPG 
in chloroform was added and the lipid mixture was vortexed and thendried as 
described for POPC. The desired amount of buffer was added and the 
dispersion vortexed. The multilamellar vesicles were sonified for 25 min under 
a stream of nitrogen (Branson sonifier S-250A equipped with a disruption 
horn, 200 W) until an almost clear dispersion of unilamellar vesicles was 
obtained. 
The diameter of the small unilamellar vesicles (SUVs) was measured by DLS 
(Nano Series NS, ZEN3600, Malvern Instruments Ltd, UK) and their average 
size was about 30 nm at all pH values. 
For the ITC measurements the peptides were solubilized in buffer solution and 
the prepared samples were monitored on a Uvikon 860 (GOEBEL 
Instrumentelle Analytik, Germany) with the buffer spectrum as a reference. A 
1 cm cuvette was used (Hellma, Jena, Germany). Peptide concentration was 
12 
 
determined from the absorption measured at 280 nm. 
Isothermal titration calorimetry was performed with a VP ITC instrument 
(Microcal, Northampton, MA). The cell volume was Vcell = 0.203 ml. The 
peptide solution and lipid dispersion were degassed un er vacuum and 
equilibrated at the experimental temperature for 10 min before filling the cells 
and syringe. The heats of reaction were corrected with the heat of dilution of 
POPC/POPG titrated into buffer. 
Raw data were processed using the Origin software provided by Microcal. 
 
2.4.4 Nuclear Magnetic Resonance (NMR) 
NMR experiments were performed in sodium dodecyl sulphate (SDS) 
solution. The samples for NMR experiments in micelles of SDS were prepared 
by dissolving an appropriate amount of peptide (1.5mM) in a SDS d25 micelle 
solution (=0.08 mol kg-1). 
NMR spectra were collected using a Bruker DRX-600 spectrometer at 300 K. 
One-dimensional (1D) NMR spectra were recorded in the Fourier mode with 
quadrature detection. The water signal was suppressed by low-power selective 
irradiation in the homo-gated mode. DQF-COSY, TOCSY, and NOESY(47-
49) experiments were run in the phase-sensitive mode using quadrature 
detection in ω1 via time-proportional phase increases of the initial pulse. Data 
block sizes were 2048 addresses in t2 and 512 equidistant t1 values. Prior to 
Fourier transformation, the time domain data matrices were multiplied by 
shifted sin2 functions in both dimensions. A mixing time of 70 ms was used 
for the TOCSY experiments. NOESY experiments were run with mixing times 
in the range of 100-300 ms. Qualitative and quantittive analyses of DQF-




2.4.5 NMR structure calculations 
Peak volumes were translated into upper distance bounds with the CALIBA 
routine from the CYANA software package.(51) The requisite pseudoatom 
corrections were applied for non-stereospecifically assigned protons at 
prochiral centers and for the methyl group. After discarding redundant and 
duplicated constraints, the final list of experimental constraints was used to 
generate an ensemble of 100 structures by the standard CYANA protocol of 
simulated annealing in torsion angle space implemented (using 6000 steps). 
No dihedral angle or hydrogen bond restraints were applied. The best 20 
structures that had low target function values (0.83-1.19) and small residual 
violations (maximum violation = 0.38 Å) were refined by in vacuo 
minimization in the AMBER 1991 force field using the SANDER program of 
the AMBER 5.0 suite.(52, 53) To mimic the effect of solvent screening, all net
charges were reduced to 20% of their real values. Moreover, a distance-
dependent dielectric constant (ε = r) was used. The cut-off for non-bonded 
interactions was 12 Å. NMR-derived upper bounds were imposed as semi-
parabolic penalty functions, with force constants of 16 Kcal/mol Å2. The 
function was shifted to be linear when the violation exceeded 0.5 Å. The best 
10 structures after minimization had AMBER energies ranging from -441.4 to 
-391.1 Kcal/mol. Final structures were analyzed using the Insight 98.0 







3.1 Antifungal activity  
The Minimum Inhibitory Concentrations (MICs) of peptides AMT2, cyclo-
AMT2, AMT1, cyclo-AMT1, AMT3 and cyclo-AMT3 were det rmined using 
a standardised microbroth dilution method for yeasts, as recommended by the 
Clinical and Laboratory Standards Institute48 (CLSI). The application of an 
endpoint less than the MIC90 was used according to CLSI recommendations 
because it proved to consistently represent the in vitro activity of the 
compounds and often provided a better correlation with other measurements of 
antifungal activity. AMT1, cyclo-AMT1, AMT2, cyclo-AMT2, AMT3 and 
cyclo-AMT3 were tested against C. albicans, C. glabrata, C. krusei, C. 
tropicalis, C. parapsilosis and C. neoformans. The antifungal antibiotics 
amphotericin B and fluconazole served as positive controls for the microbes 
and gave the expected minimal inhibitory concentrations (MICs). For the 
Candida species isolates, MICs ranged from 64 to >512 lg/mL for the linear 
compounds and from 32 to 512 lg/mL for the cyclic compounds. The MIC 
values shown in Table 1 indicate that all species ar  susceptible to the peptides 
tested; cyclic peptides have generally lower MIC values than their linear 
analogues. In particular the longest linear AMT3, having a MIC greater than 





Table 1: In vitro susceptibilities of Candida species and Cryptococcus neoformans isolates to six 
peptidesa. 
 AMT2 (µg/mL) cyclo-AMT2 
(µg/mL) 
AMT1 (µg/mL) cyclo-AMT1 
(µg/mL) 
AMT3 (µg/mL) cyclo-AMT3 
(µg/mL) 
AMB (µg/mL) FLU (µg/mL) 










































>512 64-256 256 0.03-
0.25 
0.125 4->64 64 




256 32-128 64 128-
>512 
512 32-128 64 256-
>512 
512 32-64 64 0.03-
0.125 
0.06 16->64 64 
C. tropicalis 
(20)  48 h 
128-
512 






>512 32-128 128 0.03-
0.125 
0.06 0.5-4 2 
C. parapsilosis 
(20)  48 h 
128-
512 
256 64-256 128 64-128 128 32-128 128 >512 512 32-128 128 0.06-
0.125 
0.06 1-4 2 
C. neoformans 
(35)  72 h 
8-16 16 4-8 8 16-64 64 4-16 8 8-32 16 2-8 4 0.125-
0.25 
0.25 2-64 4 
Abbreviations: AMB, amphotericin B; FLU, fluconazole; MIC, minimum inhibitory concentration; MIC90, MIC for 90% of the isolates. 
a As determined by the CLSI M27-A3 broth microdilution method
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Interestingly, all compounds are significantly more active against C. 
neoformans. Cryptococcus is a pathogenic fungus responsible for severe 
opportunistic infections. The most prominent feature of this yeast is its 
elaborate polysaccharide capsule, a complex structure that is required for 
virulence. To investigate the origin of this specificity, we tested our 
compounds against the acapsular C. neoformans strain ATCC 52817. MIC 
values against ATCC 52817 are quite similar to those f C. neoformans H99 
(16 lg/ mL for AMT2, 8 lg/mL for cyclo-AMT2, 16 lg/mL for AMT1, 8 lg/mL 
for cyclo-AMT1, 8 lg/mL for AMT3 and 4 lg/mL for cyclo- AMT3), 
indicating the absence of any specific interaction with the capsular structure. 
 
3.2 Fluorescence microscopy 
To investigate whether the peptides cyclo-AMT2 and cyclo-AMT3 bind to 
Candida cell wall, the peptides were labelled with the fluorescent dye Dap (l-
diamino propionic acid) aminoacid and incubated with the fungal cells. As 
demonstrated by fluorescence microscopy the peptides bound to the surface of
Candida albicans cells (Figure 2). 
 
    
Figure 2 Binding of cyclo-AMT2 and cyclo-AMT3 to C. albicans. ATCC 90028 (on 
the left) and C. albicans MYA-2876 (on the right). Panels show fluorescence of 
Candida cells stained with labelled with Dap conjugated cyclo-AMT3. 
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3.3 Membrane-peptide interaction 
3.3.1 Fluorescence titration measurement. 
Peptide-surfactant and peptide-liposome interactions were studied by 
monitoring the changes in the Trp fluorescence emission spectra with 
increasing surfactant concentrations. 
The fluorescence intensities of some fine vibronic structures in the tryptophan 
fluorescence spectrum show strong environmental dependance.(54, 55) In 
particular, the emission maximum shifts from 354 to 329 nm when going from 
water to an apolar medium. The quantum yield could also undergo large 
changes, the direction and extent of which depend o the system under 
consideration.(56) To evaluate the interaction capability of the peptides with 
micelle aggregates, tryptophan fluorescence of AMT1, cyclo-AMT1, AMT2, 
cyclo-AMT2, AMT3, and cyclo-AMT3 in SDS micelle solutions was 
registered. SDS micelles were chosen as representatives of anionic micellar 
systems. 
The spectra of all peptides in phosphate buffer and in a SDS micellar solution 




Figure 3 Tryptophan emission spectra (range 300-400 nm) of AMT1, cyclo-AMT1, 
AMT2, cyclo-AMT2, AMT3 and cyclo-AMT3 in aqueous phosphate buffer (solid 
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In phosphate buffer, all the spectra show a Trp emission spectrum typical of an 
aqueous environment (λmax ≈ 358 nm) indicating that the Trp side chains are 
exposed to the aqueous medium. For the linear peptides, the addition of SDS 
causes a reduction in Trp quantum yield which could be ascribed to peptide-
micelle interaction,(57) and a weak shift of the emission maximum to shorter 
wavelength (λmax ≈ 350 nm). The limited extent of the shift indicates hat the 
Trp residues remain greatly exposed to the solvent, suggesting a peptide 
positioning at the micelle surface rather than inside the inner hydrophobic 
core. For cyclo-AMT1 and cyclo-AMT2 in SDS micelles a different behaviour 
is observed, since the Trp quantum yield increases and the shift of the 
emission maximum is more evident (λmax ≈ 345 nm). Thus, our evidences 
indicate a different peptide-micelle interaction mode,(58, 59) where the Trp 
residues of cyclo-AMT1 and cyclo-AMT2 experiences a lightly more apolar 
environment than the linear analogues. Interestingly, the cyclo-AMT3 
behavior is more similar to that of the linear AMT3 than to those of the other 
cyclic peptides. 
In order to obtain further information on peptide-surfactant interaction, Trps 
fluorescence of peptides was monitored at surfactant co centrations ranging 
from premicellar to concentrated micellar solutions. A  an example, Figure 4 
contains the variation of fluorescence for AMT3 and cyclo-AMT3 at  λ= 354 





Figure 4 Trps fluorescence variation of AMT3 and cyclo-AMT3 at λ = 354 nm, with 
increasing SDS concentrations. 
 
For the six peptides, a very low amount of surfactant is sufficient to induce 
dramatic changes in the Trps fluorescence; moreover, no further change is 
observed at the point of SDS micellization (cmc =0.008 mol kg-1). This means 
that the considered peptides interact with surfactants monomers, inducing their 
aggregation.(60) 
The data reporting the variation of fluorescence with SDS concentration offer 
the opportunity for a quantification of the peptide-surfactant interaction. 
Actually, the quantitative description of a peptide interaction with 
biomembranes and related mimetic systems (vesicles, micelles) has been the 
subject of recent scientific discussion.(61) Two different approaches have 
been proposed: a partition process and a binding mechanism. For these two 
approaches two different constants are calculated, Kp,x and Ka, 
respectively.(62, 63) The former, describes the mole-fraction partitioning of 
the peptide between the solution bulk and the microscopically dispersed 
hydrophobic phase, the second is an association constant between the peptide 
































































representative model for the system under scrutiny, but the choice depends on 
the trend evidenced by Trps fluorescence at λ = 354 nm in function of 
surfactant concentration. 
In the case of our peptides, the variation of Trps fluorescence at λ = 354 nm in 
function of surfactant concentration shows a saturation trend. For this trend the 
binding approach is proved the most representative model; here, interpolation 
of the experimental Trp fluorescence data, F, by means of the proper equation 
allows the estimation Ka (association constant between the peptide and the 
surfactant) and n (surfactant molecules) as described below. 
The change in the peptide fluorescence has been described following the 
equations developed by Christiaens et al.(63) In particular, using the equation: 
0 F 1
F






F     (1) 
where F is the fluorescence intensity at a given added lipi  concentration. F0 
and [PF] are the fluorescence intensity and concentration of the unbound 
peptide, respectively, while F1 and [PL] are the fluorescence intensity and 
concentration of the peptide-lipid complex. [PL] can be obtained via the 









   (2) 
with Kd dissociation constant, Ka association constant, and [LF] free lipid 
concentration. 
The binding Eqn (2) can be rearranged to the following quadratic equation: 
2 'tot tot
tot d tot
[L ] [L ]





The parameter n, representing the formal number of phospholipid molecules 
that are involved in a binding site for one peptide, is introduced in order to 
account for the formal stoichiometry of binding ('dK = Kd/n). The solution of 
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Substitution of Eqn (4) into Eqn (1) yields an equation of F as a function of 
[Ptot] and [Ltot]. By plotting the measured fluorescence intensity as a function 
of [L tot], 
'
dK  and n can be determined through a non-linear best fitting 
procedure. Kd is obtained by multiplying of 
'
dK  by n. 
Table 2 summarizes the Ka and n values obtained for the systems under 
consideration. The Ka values, although not very high, indicate a significant 
propensity of AMT1, AMT2, AMT3, cyclo-AMT1, cyclo-AMT2 and cyclo-
AMT3 to form complexes with SDS molecules. An average of 4-6 surfactants 
interact per peptide. Interestingly, cyclo-AMT1 and cyclo-AMT2 present a 
lower Ka than the linear analogues, confirming the peculiarity of interaction as 
compared to the remaining peptides, while cyclo-AMT3 binding to SDS 





Table 2 Ka (association constant between the peptide and the surfactant/liposome), 
and n (number of surfactant molecules/vesicles interacting with the peptide, 
calculated for AMT1, AMT2, AMT3, cyclo-AMT1, cyclo-AMT2 and cyclo-AMT3 in 
SDS micelle solutions. 
 solvent medium Ka×10
-2/M-1 n 
AMT1 SDS micelles 3.8±0.4 4±1 
AMT2 SDS micelles 3.3±0.4 5±1 
AMT3 SDS micelles 3.4±0.3 4±1 
cyclo-AMT1 SDS micelles 2.2±0.2 6±2 
cyclo-AMT2 SDS micelles 2.0±0.4 6±1 
cyclo-AMT3 SDS micelles 5.5±0.4 6±1 
    
    
 
3.3.2 Isothermal Titration Calorimetry ITC. 
ITC is a thermodynamic technique that directly measure  the heat released or 
absorbed during a biomolecular binding event. Measurement of this heat 
allows accurate determination of binding constants (K), reaction stoichiometry 
(n), enthalpy (∆H) and entropy (∆S), thereby providing a complete 
thermodynamic profile of the molecular interaction in a single experiment. 
Because ITC goes beyond binding affinities and can elucidate the mechanism 
of the molecular interaction, it has become the method of choice for 
characterizing biomolecular interactions. 
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To study lipid-peptide interaction by ITC there are two different type of 
titration.(64)  
In the first titration mode the peptide solution is injected into the lipid 
dispersion contained in the calorimeter cell. In this titration the lipids vesicles 
are in excess compared to the peptide, so all peptide molecules injected bind 
the vesicle surface, provided the binding constant is sufficiently large. Each 
injection gives the same heat of reaction hi, and hi /δni provide the enthalpy of 
binding, ∆H0. 
In the second titration mode the peptide contained i  the calorimeter cell is 
titrated with lipid vesicles injections. As this type of titration was previously 
preferred to study AMT1 and cyclo-AMT1 binding to PO C vesicles(65) we 
have adopted this titration mode and experimental conditions for our 
experiments. 
Peptide-lipid interaction: electrostatic/hydrophobic factor 
The first measurements investigated the AMT interaction to POPC/POPG 
(75/25, M/M) SUVs at pH 7.4 and 25°C. POPC/POPG 3:1 M/M is often used 
to mimic the electrostatic charge of cytoplasmic membrane of yeast as C. 
Albicans.(66, 67)  
Figure 5 shows the calorimetric trace flow obtained titrating AMT peptides 
with the SUVs system described above and the integra d reaction heats 




Figure 5 Titration of each peptide with POPC/POPG (75/25 M/M) SUVs at pH 7.4 
and 25°C. UP: ITC trace (differential heating power vs. time). Down: the cumulative 
heat of reaction as a function of the lipid to-to-peptide molar ratio. 
 
In each titration the binding of peptide to vesicles produce exothermic heat of 
reaction. The exothermic heat flow decreases with increasing number of 
injections because less and less peptide is available for binding. The residual 
heat is the heat of dilution of the lipid dispersion n the buffer. 
The molar binding enthalpy ∆H0 of peptides to POPC/POPG SUVs can be 
determined from the total heat released in the titration, ∑hi, and the molar 
amount of peptide in the sample cell, n0, according to 
∆ = ∑ 	     (1) 



































































































































































































The enthalpy of the reaction is calculated according to Equation (1) assuming 
that the total amount of peptide in the calorimeter is bound. The calculated 
binding enthalpies ∆H0 are listed in Table 3. 
High-sensitivity calorimetric experiments can allow the definition of a binding 
isotherm,(68) Xib = f(cf). It describes the extent of binding, X
i
b, as a function of 
the concentration of free peptide, cf at each injection of the titration. X
i
b is 
defined as the ratio between the molar amount of bound peptide, nipep bound, and 





    (2) 
niL is given by the lipid concentration in the syringe, the volume of injection 
and the number i of injections performed. nipep bound is determined from the 




   (3)  
with cpep
0 the total peptide concentration in the calorimeter c ll and Vcell the 
volume of the calorimeter cell. The molar amount of peptide bound to the lipid 
membrane (equation 3) combined with the principle of mass conservation 
allows the calculation of the free peptide concentration in solution. This 
provides the description of the binding isotherm without assuming a specific 
binding model. 
The calculation of further thermodynamic parameters such as the binding 
constant or the free energy of the reaction requires th  analysis of the binding 
isotherm. In the present context it is based on a surface partitioning model in 
which the peptide binding to the lipid membrane is dependent on the peptide 
affinity for the lipid and the concentration of peptide, cM, found immediately 




 = %	&'    (4) 
with K0 the intrinsic binding constant. The surface partitioning model takes 
into account the attraction of positively-charged peptides to the negatively-
charged membrane surface. The peptide concentration at the membrane 
surface, cM, is therefore higher than the peptide concentration in the bulk, cf. 




./ 0   (5) 
where zp is the peptide effective charge, Ψ is the membrane surface potential, 
F0 is the Faraday constant and RT is the thermal energy. Ψ can be calculated 
from the Gouy-Chapman theory. It leads to the peptid  concentration at the 
membrane surface after each lipid injection and finally to the intrinsic binding 
constant K0, according to equation (4). 
The free energy of binding ∆G0 follows from: ∆G0 = -RTln(55.5 K0). The 
factor 55.5 is the molar concentration of water and corrects for the cratic 
contribution. The binding entropy can be derived from the second law of 
thermodynamics, ∆G0 = ∆H0-T∆S0. 









Table 3 Thermodynamic parameters for the binding of linear and cyclic AMT to 
POPC/POPG (75/25 M/M) SUVs at pH 7.4 and 25°C. 
POPC/POPG 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) 
AMT1 700 -9,47 -6,26 -10,78 
Cyclo-AMT1 400 -10,58 -5,93 -15,62 
AMT2 550 -9,15 -6,11 -10,18 
Cyclo-AMT2 800 -7,8 -6,34 -4,92 
AMT3 600 -7,44 -6,17 -4,27 
Cyclo-AMT3 400 -7,87 -5,93 -6,52 
 
For all the peptides the intrinsic binding constants K are not high  and vary 
between 400 and 800 M-1. The low value of binding constant suggests that te 
peptides do not penetrate the hydrophobic core of the vesicles but are adsorbed 
on their external surface. ∆H values are generally higher than ∆G values in 
absolute value; furthermore ∆S value are always negative. These data suggest 
that the insertion of the peptide into the lipid bilayer is driven by enthalpy and 
opposed by entropy. 
To investigate the role of electrostatic/hydrophobic contribution to peptide-
vesicles interaction, AMT3 and cyclo-AMT3 were titrated at different pH 
values with POPC/POPG and POPC SUVs.  
The titration curves of AMT3 and cyclo-AMT3 with POC/POPG SUVs 
show an exothermic profile (Figure 6). Thermodynamic parameters are 





Figure 6 Titration of AMT3 and cyclo-AMT3 with POPC/POPG (75/2  M/M) SUVs 
at 35°C and different pH value. UP: ITC trace (differential heating power vs. time). 
Down: the cumulative heat of reaction as a function of the lipid to-to-peptide molar 
ratio. 
 
For AMT3 a gain in free energy and an increasing of  binding constant show 
that the membrane binding is enforced by pH decrease. In contrast, cyclo-
AMT3 show no variation of binding constant in depend ce of pH, but just a 
slight gain in free energy (Table 4). For both peptides the binding to vesicles is 
enthalpy driven. 
 





































































































































































































AMT3 pH 7.4 AMT3 pH 7 AMT3 pH 6.5 
AMT3 pH 6 Cyclo-AMT3 pH 6 Cyclo-AMT3 pH 7.4 
30 
 
Table 4 Thermodynamic parameters for the binding of AMT3 and cyclo-AMT3 to 
POPC/POPG (75/25 M/M) SUVs at 35°C  and different pH value. 
POPC/POPG 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) pH T(°C) 
AMT3 800 -7,45 -6,55 -2,93 7.4 35 
AMT3 900 -9,06 -6,62 -7,92 7.0 35 
AMT3 1700 -9,21 -7,01 -7,14 6.5 35 
AMT3 6000 -9,22 -7,78 -4,67 6.0 35 
Cyclo-AMT3 400 -7,87 -5,93 -6,52 7.4 25 
Cyclo-AMT3 400 -9,54 -6,12 -11,09 6.0 35 
 
To study the hydrophobic contribution in peptide-vesicles interaction AMT3 
and cyclo-AMT3 were titrated with neutral POPC SUVs (Figure 7). The 
results of peptide titrations with POPC SUVs is summerized in Table 5. 
 
Figure 7 Titration of AMT3 and cyclo-AMT3 with POPC SUVs at 35°C and pH 6. 
UP: ITC trace (differential heating power vs. time). Down: the cumulative heat of 
reaction as a function of the lipid to-to-peptide molar ratio. 
 









































































Table 5 Thermodynamic parameters for the binding of AMT3 and cyclo-AMT3 to 
POPC SUVs at 35°C and pH 6. 
POPC 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) pH T(°C) 
AMT3 2500 -5,39 -7,25 6,03 6.0 35 
Cyclo-AMT3 800 -5,25 -6,55 4,22 6.0 35 
 
Hydrophobic constant of AMT3 decreases from 6000kcal/mol with 
POPC/POPG SUVs (Table 4) to 2500 kcal/mol with POPC SUVs (Table 5). 
Also the free energy (-7,25kcal/mol; Table 5) is slightly lower than with 
POPC/POPG SUVs (Table 4). 
On the contrary, cyclo-AMT3 titrated with POPC SUVs shows a slight 
increase in binding constant and free energy in comparison to the values 
observed in the titration with POPC/POPG SUVs (Table 4). 
For both peptides the interaction with POPC vesicle is entropy driven as 
shown by positive value of entropy (Table 5). 
Taken all together the ITC data can be interpreted supposing that at lower pH 
the basic residue of peptides are protonated and thus attracted by the negative 
charge of POPC/POPG SUVs. This electrostatic effect is highly evident for 
AMT3-vesicles interaction as compared to  cyclo-AMT3 vesicles interaction. 
The role of His in peptide-vesicles interaction 
To clarify the effect of the presence of His residues in peptide-vesicles 
interaction, AMT2 was titrated with POPC/POPG SUVs at different pH values 
(Figure 8). 
A slight gain in free energy and an increase in binding constant show that the 
membrane binding is facilitated by pH decrease (Table 6). The entropy value 
shows that moving from pH 7 to pH 6 the system become more disordered. 
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The results of Table 4 and Table 6 show that in the same conditions the 
binding of AMT3 to vesicles has a lower free energy, an higher binding 
constant and is more disordered than AMT2 binding. These data suggest that  
His residues are important for the interaction of the wo peptides with the 
vesicle surface.  
 
 
Figure 8 Titration of AMT2 with POPC/POPG (75/25 M/M) SUVs at 35°C and 
different pH value. UP: ITC trace (differential heating power vs. time). Down: the 
cumulative heat of reaction as a function of the lipid to-to-peptide molar ratio. 
 
Table 6 Thermodynamic parameters for the binding of AMT2 to POPC/POPG (75/25 
M/M) SUVs at 35°C  and different pH value. 
POPC/POPG 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) pH T(°C) 
AMT2 350 -10,92 -6,04 -15,83 7.0 35 
AMT2 450 -10,78 -6,20 -14,88 6.5 35 
AMT2 1000 -8,82 -6,69 -6,93 6.0 35 
 
 
































































































AMT2 pH 7 AMT2 pH 6.5 AMT2 pH 6 
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The role of membrane fluidity in peptide-vesicles interaction 
To understand the influence of membrane fluidity we repeated the titration of 
AMT3 and cyclo-AMT3 with POPC/POPG+cholesterol, and 
POPC/POPG/POPE+cholesterol SUVs that mimics the composition of the 
outer leaflet of yeast membrane (Figure 9).(66, 67) 
Cholesterol is used as mimetic of ergosterol, the sterol component in yeast 
membrane. Cholesterol is an essential component in the membranes of most 
eukaryotic cells, in which it mediates many functions including membrane 
fluidity, permeability and the formation of ordered membrane domains. The 
presence of cholesterol decreases the membrane fluidity. 
POPC/POPG/POPE/cholesterol 50/25/25 M/M/M bilayers are more densely 
packed than POPC/POPG/cholesterol 75/25 M/M bilayers.(71) In contrast to 
POPC, the head group of POPE is a primary amine that makes it capable for 
the formation of intra and intermolecular hydrogen bonds to lipid phosphate 
groups.(72) As a result, the water-lipid interface of a POPE membrane is more 
densely packed than POPC membrane. 
The results of titrations are summerized in Table 7 and 8. 
The free energy of AMT3 increases from -7.01 Kcal/mol, when titrated with 
POPC/POPG SUVs (Table 4) to -6,47 and -6,37 Kcal/mol when titrated with 
POPC/POPG/cholesterol (Table 7)and POPC/POPG/POPE/cholesterol (Table 
8) respectively. The binding constant decreases from 1700 kcal/mol (Table 4) 
to 700 M-1 and 600 M-1 titrating with POPC/POPG/cholesterol (Table 7) and 
with POPC/POPG/POPE/cholesterol (Table 8). Interestingly the ∆H increases 
from -9,21 to -7,37 and -5,36 kcal/mol while the ∆S increases from -7,14 to -
2,93 and + 3,29 cal/mol K. Thus, with POPC/POPG/POPE/cholesterol the 
peptide-vesicle interaction is entropy driven while the interactions with the 
previous liposome system were enthalpy driven. 
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The binding constant of cyclo-AMT3 titrated with POC/POPG/cholesterol 
SUVs is 250 M-1 and it slightly decreases to 150 M-1 when the peptide is 
titrated with POPC/POPG/POPE/cholesterol vesicles. The results of the 
titrations of cyclo-AMT3 with the two vesicles system show an increase of ∆G 
and ∆H and a decrease of ∆S (see Tables 7 and 8). The data show that the 
peptide-membrane interaction is opposed by membrane rigidity. 
 
Figure 9 Titration of AMT3 and cyclo-AMT3 with POPC/POPG and cholesterol 
SUVs and with POPC/POPE/POPG and cholesterol SUVs at 35°C and pH 6.5. UP: 
ITC trace (differential heating power vs. time). Down: the cumulative heat of reaction 
as a function of the lipid to-to-peptide molar ratio. 








































































































































Table 7 Thermodynamic parameters for the binding of AMT3 and cyclo-AMT3 to 
POPC/POPG and cholesterol SUVs at 35°C and pH 6.5. 
POPC/POPG and cholesterol 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) pH T(°C) 
AMT3 700 -7,37 -6,47 -2,93 6.5 35 
Cyclo-AMT3 250 -7,85 -5,84 -6,54 6.5 35 
 
Table 8 Thermodynamic parameters for the binding of AMT3 and cyclo-AMT3 to 
POPC/POPG/POPE and cholesterol SUVs at 35°C and pH 6.5. 
POPC/POPG/POPE and cholesterol 
peptide K(M-1) ∆H(kcal/mol) ∆G°(kcal/mol) ∆S°(cal/(mol K)) pH T(°C) 
AMT3 600 -5,36 -6,37 3,29 6.5 35 
Cyclo-AMT3 150 -6,33 -5,52 -2,62 6.5 35 
 
 
3.3 Conformational analysis 
3.3.1 CD spectroscopy 
The conformational structure of cyclo-AMT1 was previously solved.(18, 38) 
in SDS micelles. SDS micelle solution is considered a simple plasma 
membrane- mimicking system. To compare our results to AMT1 and cyclo-
AMT1, we studied the conformational behaviour of AMT2, cyclo-AMT2, 
AMT3 and cyclo-AMT3 in SDS micelle system. 
A preliminary study of conformational preferences of cyclic and linear AMT 
derivatives were screened by CD spectroscopy. All CD spectra were recorded 
in water and in sodium dodecyl sulphate (SDS) micelle solution. CD spectra of 
linear and cyclic AMT derivatives were recorded in this system to explore 
their propensity to assume specific secondary structu es in response to the 
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presence of membrane-mimicking interfaces. CD spectra of AMT1, AMT2 
and AMT3 indicate the preponderance of disordered conformations both in 
water and in SDS micelles. CD spectra of cyclic peptid s recorded in water 
and in SDS micelles are shown in Figure 10. They were quantitatively 
evaluated using the DICHROWEB interactive website (SELCONN 
algorithm); consistently with this analysis, a significant presence of turn 
conformation is evident in cyclo-AMT1 cyclo-AMT2 and cyclo-AMT3 in 
water. CD spectrum of cyclo-AMT2 in SDS micelles is similar to that 
exhibited in water solution; on the contrary CD spectra of cyclo-AMT1 and 
cyclo-AMT3 in SDS micelle solution have the shape characteristic of random 
coil conformation.  
 
 
Figure 10. CD spectra of cyclo-AMT1, cyclo-AMT2 cyclo-AMT3 in water (on the 







3.3.2 NMR Spectroscopy.  
The NMR structure of cyclo-AMT1 in SDS micelles was previously 
solved.(38, 65) In this work, NMR structure of AMT2, AMT3, cyclo-AMT2 
and cyclo-AMT3 are solved and compared to cyclo-AMT1 structure. 
Accordingly a whole set of 1D and 2D proton spectra were recorded in pure 
SDS micelles. To check the absence of self-aggregation, spectra were acquired 
in the peptide concentration range of 0.5-15 mM. No significant changes were 
observed in the distribution and shape of 1H resonances, indicating that no 
aggregation phenomena occurred in this concentration range. The NOESY 
spectra of linear and cyclic peptides acquired in SDS micelles are showed in 
Figure 11. The spectra shown considerable high quality NOE cross-peaks that 
were essential to assign all resonance and to understand the conformational 
structure of peptides in exam. The chemical shift assignments of proton 
spectra were achieved via the standard systematic applic tion of TOCSY and 
NOESY experiments. The proton chemical shifts of peptid s in SDS micelle 







Figure 11 . Low field region of NOESY spectra of AMT2 (A) cyclo-AMT2 (B)  






Table 9 1H chemical shift of AMT2 in SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
His1  4.446 3.420  7.374 8.492  
Arg2 8.546 4.273 1.697/1.651 1.544 3.058 6.976  
Arg3 8.198 4.245 1.621 1.475/1.427 3.074 7.014  












Arg6 6.843 4.052 1.412/1.080 0.933/0.760 2.823 6.870  
Phe7 6.846 4.440 3.197/2.654  6.940 7.166 Hζ 7.081 
 
 
Table 10 1H chemical shift of cyclo-AMT2 in SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
His1 7.916 4.394 3.498/3.414  7.209 8.524  
Arg2 8.255 4.391 1.998/ 1.640 3.238/3.151 7.213  
Arg3 7.942 4.131 1.628 1.262/1.152 2.951/2.833 6.973  












Arg6 6.383 3.504 0.958/0.536 0.300/-0.153 2.500/2.403 6.619  







Table 11 1H chemical shift of AMT3 in SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
His1  4.405 3.407  7.501 8.683  
Gly2 8.639 4.026/3.985      
His3 8.372 4.792 3.268/3.159  7.280 8.496  
Arg4 8.220 4.188 1.580 1.460 2.992 6.979  
Arg5 8.008 4.053 1.509/1.477 1.347 2.994 6.945  












Arg8 7.072 4.042 1.410/1.139 0.949/0.796 2.845 6.885  
Phe9 7.064 4.554 3.209/2.759  7.046 7.197 Hζ 7.107 
 
 
Table 12 1H chemical shift of cyclo-AMT3 in SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
His1 8.315 4.540 3.342/3.189  7.328 8.594  
Gly2 8.163 3.994      
His3 8.261 4.590 3.336/ 3.260     
Arg4 8.174 4.260 1.827/ 1.729 1.516/ 1.424 3.006 7.097  
Arg5 7.915 4.085 1.593 1.347/ 1.294 3.002 6.942  




Trp7 7.644 4.348 3.339  7.270 Hε1 9.972  
Arg8 7.266 3.614 1.079/ 1.034 0.371/ 0.336 2.561/ 2.419 6.722  






Figure 12 shows the NOE connectivities of AMT2, AMT3, cyclo-AMT2 and 
cyclo-AMT3 as derived from NOESY spectra in SDS micelles. Sequential 
NH-NH(i, i+1), and sporadic medium range CHα−NH(i, i+2) NOE effects 
were observed in the NOESY spectrum of AMT2.  AMT3, cyclo-AMT2 and 
cyclo-AMT3 in pure SDS micelles, show sequential NH- (i, i+1) effects 
and several medium range NOEs including in particular CHα-NH(i, i+2) and 
NH-NH(i, i+2) along different triads of the sequencs. 
 
 
Figure 12 NOE connectivities of AMT2, cyclo-AMT2, AMT3, cyclo-AMT3 Cyclo-
AMT3, in SDS micelle solution. 
 
The structural calculations of AMT2, cyclo-AMT2, AMT3 and cyclo-AMT3 
in pure SDS micelles, were carried out using CYANA software on the basis of 
NOE data. This data was transformed into interprotonic distances and imposed 
as restraints in the calculation. 
Figure 13 shows NMR structure bundles of AMT2, cyclo-AMT2, AMT3, 
cyclo-AMT3 in SDS micelles. Analysis of AMT2 and cyclo-AMT2 structure 
bundle shows high structural agreement between the calculated conformers 
(RMSD < 0.80 Å), however the evaluation of backbone dihedral angles 




On the contrary PROMOTIF analysis of AMT3 structure bundle,(73) points to 
the presence of regular γ-turn structures on residues His3-Arg5 with H-bond 
between C=O His3 and HN Arg5  stabilizing the γ-turn structures. cyclo-
AMT3 shows the preference for regular turn structures in Trp6-Phe9 segment. 
All the calculated structures show a common, ordered orientation of side 
chains confirming the preponderance of ordered structu es in micelle solution. 
 
 







Several short membrane-active peptides have shown antifungal activity due to 
their interfacial properties.(23-25) AMT1, a peptide selected from a synthetic 
combinatorial library, and its cyclic analogue cyclo-AMT1 were recently 
shown to possess antimicrobial and haemolytic activity.(39, 65) 
AMT2, cyclo-AMT2, AMT3 and cyclo-AMT3 (Figure 1) wer  designed by 
adding to AMT1 and cyclo-AMT1 one and two His residues, respectively. His 
residues, which contain an imidazole ring in their side chains, were added in 
an attempt to confer to new peptides, activity analogous to the imidazole ring 
of the azole antifungal compounds. 
Antifungal tests of the peptides synthesized show even marginal antifungal 
activity against the selected fungal species tested: due to their sequence typical 
of the AMPs this fungicidal activity may be related to peptide-membrane 
destabilising ability. 
Linear compounds are less active than their cyclic analogues. In agreement 
with CD data, which show minimal regular secondary structures in linear 
peptides, the conformational flexibility seems to prevent the interaction 
between the peptides and the fungal target. On the contrary, the higher activity 
exhibited by the cyclo-peptides indicates that limited peptide conformational 
freedom is important for antifungal activity, probably due to a required 
orientation of the amino acid side chain in the peptide- membrane interaction. 
In addition higher activity of the cyclic peptides could be also caused by the 
improved stability of the cyclic compound against proteolytic degradation. 
The data show that all peptides tested possess very low MIC90 values against 
C. neoformans. These results are promising for drug development. C. 
neoformans infection is a life-threatening complication for 
immunocompromised hosts, being the main cause of fatal meningoencephalitis 
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in AIDS patients and producing fatal cryptococcosis in patients who have 
undergone organ transplants. Thus new compounds acting against this fungus 
are highly desirable. Experiments on capsular strains of C. neoformans 
excluded a selective interaction of our peptides with the most prominent 
feature of this yeast, the capsular structure, indicating that the specificity 
against C. neoformans depends on interaction with a C. neoformans-specific 
target. Due to their sequence typical of the CAPs the fungicidal activity may 
be related to peptide-membrane destabilising ability. 
To evaluate the impact that the interaction with the fungal membrane may 
have on the antifungal activity of the peptides, we investigated the structural 
behaviour of AMT2, cyclo-AMT2, AMT3, cyclo-AMT3 in membrane 
mimetic systems represented by SDS micelles. The ability of the cyclo-
peptides to interact with the fungal cell surface of Candida Albicans was 
monitored using fluorescence microscopy. Observation by fluorescence 
microscopy of Candida Albicans cells incubated with Dap labelled cyclo-
AMT3, confirmed the preference of cyclo-AMT3 to be localized on the 
surface of the cell. 
Fluorescence spectra indicate that all the peptides have tendency to be exposed 
to the aqueous medium. In the presence of increasing amounts of SDS, they 
are localized at the interface between the aqueous and the lipid media, 
avoiding the membrane hydrophobic core. Specifically peptides show strong 
interactions with detergent monomers (Table 2).  
The binding of AMT peptides to phospholipid vesicles was 
thermodynamically studied by isothermal titration calorimetry. Accordingly to 
the fluorescence microscopy results, ITC data evidence low values of binding 
constant (see tables 3, 7, 8),  suggesting that the peptides do not penetrate the 
hydrophobic core of the membrane, but lye on the external surface of the 
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membrane. Calorimetric study also show that for linear peptides the affinity 
for the membrane surface depends on electrostatic interaction. (table 4-5); 
while the interaction of cyclic peptides with liposome surface is more 
dependent on hydrophobic contribution (table 4-5).  
 
NMR study of peptides in micelle solution allows the calculation of 3D model 
to interpreter  in term of molecular structure the behaviour of cyclo-peptides at 
the membrane interface. NMR structure bundles evidence high structural 
agreement between the calculated conformers (RMSD < 0.5), with regular turn 
structures prevalent on WWRF segment of cyclic analogues. A common 
orientation of the side chains is evident. In particular in the cyclic peptides, 
interactions between the side chains of WRF residue ar  evident thanks to 
cation-pi interactions involving the guanidino moiety of Arg and the aromatic 
rings of Trp and Phe. This interaction, that may be the driving force for the 
stabilization of the peptide conformations, is  more favoured in the cyclic 
analogues as compared to the linear peptides. Here inde d, the side chains of 
Trp, Arg and Phe appear to be clustered on one surface of the cycle (Figure 
14). In particular, cyclo-AMT2 presents on one side of its cyclic scaffold the 
side chains of the three residues WRF, whereas cyclo-AMT3 presents on one 
side of its cyclic scaffold the side chains of the ree residues WRF in addition 
to the other Arg that may contribute to enforce theinteraction with the 
negative charges of the membrane. This organization of the side-chain, that 
confirms the calorimetric data indicating an interaction of cyclic peptides 
based on hydrophobic forces, may be the basis to rati nalize the relation 





Figure 14 Comparison of the best NMR models of AMT2, cyclo-AMT2, 
AMT3, cyclo-AMT3. 
 
Fluorescence spectroscopy, fluorescence microscopy and calorimetric 
observations, lead to exclude an unspecific mechanism of activity based on  
the destabilization of the membrane cell: the peptides do not form membrane 
pores, neither penetrate membrane cell, but they are localized on the 
membrane surface, exerting their antimicrobial activity possibly for interaction 
with a specific target. On these bases  the positioning of the peptides on the 
membrane surface is crucial for  an effective interaction with the target. Trp 
and Arg residues are known to be residues able to stabilize the interaction with 
membrane cell.(74) The clustering of such residues on one surface of the 
cyclo-AMT2 and cyclo-AMT3, could stabilize the positioning of the peptides 
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Interactions between proteins/peptides and phospholipid bilayers are 
fundamental in a variety of key biological processes. Among these, membrane 
fusion is one of the most relevant, being involved in cell growth, sub-cellular 
compartmentalization, mitochondrial remodelling, horm ne secretion, 
neurotransmission, and carcinogenesis.(1) Membrane fusion is also a rate-
determining step in viral infection by ‘enveloped’ viruses. These viruses, 
whose capsid is enclosed by a phospholipid bilayer, enter the target cell by 
fusion of their own envelope with the cell membrane. I  this process, specific 
viral proteins, named fusion proteins, interacting with both viral and cellular 
membranes, facilitate their fusion.(2) The fusion is accomplished through a 
common mechanism of action, in which a large scale protein conformational 
change is coupled to apposition and merging of the two bilayers (Figure15).(3) 
 
Figure 15 Fusion between viral envelope and cell membrane. 
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There is converging evidence that different domains of the viral fusion protein 
cooperate, playing different roles, in driving membrane fusion. A distinctly 
hydrophobic sequence, usually named fusion peptide, is deputed to enter the 
target cell membrane “anchoring” the virus on it. This is a necessary, but not 
sufficient, step for membrane fusion: Even in the pr sence of a bridging 
protein, the two opposing membranes tend to preserv their integrity because 
of the high energy required for phospholipid re-arrangement.(4) Other 
domains of the fusion protein are hypothesized to interact with the 
membranes, lowering the energetic barrier thus allowing their final fusion. 
Particularly, the researchers’ interest has focused on the membrane-proximal 
external region (MPER), also named pre-transmembrane domain.(5) 
Both the human immunodeficiency virus (HIV) and thefeline analogue (FIV) 
affect cell entry via a mechanism that involves surface glycoproteins named 
gp41 and gp36, respectively.(6-8) Both proteins present a tryptophan-rich 
MPER domain, whose action has been indicated to be crucial in the membrane 
fusion process (figure 16).(9-12). 
 
 
Figure 16 Domains of gp36 of FIV and gp41 of HIV1 and HIV2. CHR is C-terminal 
heptad repeat; MPER is membrane-proximal external region; MSR is membrane 
spanning domain. 
 
Peptides deriving from MPER of gp41 and gp36 are abl to prevent HIV- and 
FIV-cell membrane fusion.(13-18) The antiviral activity is likely to derive 
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from adsorption of the peptide on the external surface of the target-cell 
membrane, where it competes with the TM glycoprotein of the virus.(19) 
We identified  a 20-mer synthetic peptide (P59) corresponding to the fragment 
767-786 of  the membrane proximal ectodomain of FIV transmembrane 
glycoprotein. This peptide potently inhibited the growth of tissue culture-
adapted FIV in feline fibroblastoid CrFK cells.  Antiviral activity of p59 was 
found to map to a short segment containing three conserved Trp residues, a 
derivative of eight amino acids (770W-I777), designated C8. Peptide C8 
activity was found to be dependent on conservation of the Trp motif. 
Preliminary structural studies showed that peptide C8 possesses a 
conformational propensity highly uncommon for peptides of its size, which 
may account for its considerable antiviral potency in spite of small size.(18) 
Considering the involvement of these fragment in the processes mediating the 
fusion of virus and host cell membranes the characte ization of P59 and C8 in 
membrane mimetic systems seems particularly interesting.  Accordingly the 
structural behavior of P59 and C8 in different membrane models was 
extensively explored by means of several different biophysical techniques.   
ESR and fluorescence experiments, using spin-labeled lipids, demonstrated 
that the P59 peptide associates with lipid bilayers.(20) by binding at the 
membrane surface or polar–apolar interface. This is consistent with high-
resolution nuclear magnetic resonance (NMR) analysis of P59 in micellar 
environments, which revealed a region of secondary structural order in the 
sequence extending from Trp770 to Ile777 (21) In particular, an amphipathic, 
turn-helical structure forms, in which the polar orcharged residues are 
positioned on one side, with the opposite side occupied by hydrophobic 
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residues including the three tryptophans, which have  propensity to localize 
to the polar–apolar interface of membranes. (22, 23) 
Biophysical characterization of C8 in dimyristoylphosphatidylcholine 
liposomes (DMPC) bilayers, by means of ESR,fluorescence and CD 
spectroscopies showed that C8 adsorbs strongly on the bilayer surface. This 
data, although derived from a large volume of experim ntal work,  depict only 
a preliminary view of C8 interaction with membrane cell. A clear conceptual 
framework for the mechanism of action of C8 on the bilayer microstructure is 
lacking and the exact nature and the extent of Trp-lipid interactions remains 
unresolved. 
In this context the aim of the present experimental work is the characterization 
of the conformational propensities of C8 in membrane mimetic system using 
high resolution NMR data.  Structural investigation f C8-POPC interactions 
on the lipid bilayer microstructure to present a clear description at a molecular 













2.1 Peptide synthesis 
The aminoacid sequence of C8 peptide is Ac-Trp-Glu-Asp Trp-Val-Gly-Trp-
Ile-CO-NH2 and the deuterated C8-d5all was synthesized including Trp-d5 in all 
the Trp positions. Trp-d5 including deuterons atoms on indole ring and NH-
Fmoc protected group (L-Tryptophan-N-Fmoc(Indole-D5), 98%) was 
purchased from Cambridge Isotope Laboratories Incs. (Andover, MA, USA). 
C8 and C8-d5all were synthesized on a manual batch synthesizer (PLS 4°-4, 
Advanced ChemTech, Louisville, KY, USA) using a Teflon reactor (10 mL), 
applying the Fmoc/tBu solid phase peptide synthesis (SPPS) procedure. The 
Rink-resin was swelled with DMF (1 mL/100 mg of resin) for 3 h before use. 
Stepwise peptide assembly was performed by repeating for each added amino 
acid the following deprotection–coupling cycle: 1) Swelling: DMF (1 mL/100 
mg of resin) for 5 min; 2) Fmoc-deprotection: resin i  washed twice with 20% 
piperidine in DMF (1 mL/100 mg of resin, one wash for 5 min followed by 
another wash for 20 min); 3) Resin-washings: DMF (5 min); 4) Coupling: 
scale employing HBTU/HOBt/DIPEA (2.5:2.5:3.5 eq.) as the coupling system 
and 2.5 eq. of the Fmoc protected amino acids. Each coupling was monitored 
by Kaiser test,(24) whose negative response indicated that recouplings were 
not needed; 5) Resin-washings: DMF (3°-5 min) and DCM (1°-5 min). After 
deprotection of the last NH-Fmoc group, peptides were acetylated with a 
solution of acetic anhydride (12.5%) and DIPEA (2.5%) in DMF for 2 h.  
The protected hydrogenated peptide C8 was cleaved from the resin by 
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treatment with TFA/H2O/thioanisole (reagent K) (95:2.5:2.5 v/v). In contras , 
to avoid D2O/H2O exchange, the protected peptide C8-d5all was cleaved from 
resin by treatment with TFAd/D2O/TIS at a ratio of 10 mL to 0.5 g of resin at 
room temperature for 3 h.29,30 Trifluoroacetic acid-D (D, 99.5%) (TFAd) and 
deuterium oxide (D, 99.9%) (D2O) were purchased from Cambridge Isotope 
Laboratories Incs. All the other reagents and solvents were purchased from 
Aldrich (St. Louis, MO) and were used as received. 
After filtration of the exhausted resin, the solvent was concentrated in vacuo 
and the residue was triturated with ether. The crude peptide was purified by 
preparative reversed phase high performance liquid chromatography (HPLC) 
using a Jupiter [Phenomenex, Anzola Emeilia (BO), Italy] C18 column (25°-
4.6 cm, 5 µ, 300 Å pore size). The column was perfused at a flow rate of 3 
mL/min with a mobile phase containing solvent A (0.1% TFA in water). A 
linear gradient from 50% to 90% of solvent B (acetonitrile in 0.1% TFA) for 
40 min was adopted for peptide elution. The pure fraction was collected to 
yield a white powder after lyophilization. The molecular weight of the 
compound was determined by mass spectral analysis, using a Finnigan LCQ-
Deca ion trap instrument equipped with an electrospray source (LCQ Deca 
Finnigan, San Jose, CA, USA). The samples were directly infused into the ESI 
source using a syringe pump set at a flow rate of 5 µl/min. Data were analyzed 
with Xcalibur software. 
 
2.2 Sample preparation 
The phospholipid palmitoyl oleoyl phosphatidylcholine (POPC) was obtained 
from Avanti Polar Lipids (Birmingham, AL, USA). 
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POPC liposomes, to be used for ESR, CD and spectrofluo imetry experiments, 
were prepared by pouring appropriate amounts of phos lipid in 
dichloromethane/methanol (2/1 v/v) in small test tubes. For ESR experiments 
1% wt/wt of spin-labeled phosphatidylcholines in ethanol was added. 
Dichloromethane, methanol and ethanol, HPLC-grade solvents, were obtained 
from Merck (Darmstadt, Germany).A thin film of the lipid was produced by 
evaporating the solvent with dry nitrogen gas. Final tr ces of solvent were 
removed by subjecting the sample to vacuum desiccation for at least 3 h. The 
samples were then hydrated with 20-50 µL of 10 mM phosphate buffer, 137 
mM NaCl, 2.7 mM KCl, pH 7.4 (PBS) and vortexed, obtaining a suspension 
of MultiLamellar Vesicles (MLVs). For ESR experiments this suspension was 
transferred to a 25-µL glass capillary and flame sealed. For CD and 
spectrofluorimetry experiments, Large Unilamellar Vesicles (LUVs), obtained 
from MLVs by nine-fold extrusion through a polycarbonate membrane of 100-
nm pore size, were preferred for their lower radiation scattering. Liposomal 
samples (both MLVs and LUVs) containing the peptide w re prepared in a 
similar manner, except that the lipid film was hydrated directly with a peptide 
solution in PBS.  
For CD experiments sodium dodecyl sulphate (SDS) and dodecyl 
phosphorcoline (DPC) were used. 
For NMR experiments deuterated sodium dodecyl sulphate (SDS-d25) and 
deuterated dodecyl phosphorcoline (DPC-d38) were used. 
To conduct CD and NMR experiments in a water solutin, dry C8 was 
dissolved in phosphate buffer (25mM pH 6.8). This yielded final 
concentrations of 0.15 mM (CD experiments) and 1.5 mM (NMR 
experiments). For NMR samples, a H2O/D2O mixture (90:10, v/v) was used. 
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The obtained solutions were titrated with increasing amount of surfactant 
(SDS, DPC) moving from submicelle to micelle concentration. 
The samples for CD and NMR experiments in mixed micelles of DPC and 
SDS (90/10, M/M) were prepared by dissolving the peptid  (0.15 mM for CD 
experiments and 1.5 mM for NMR experiments) in a DPC/SDS (90/10, M/M) 
water mixture. 
 
2.3 ESR spectroscopy 
Spin-labeled phosphatidylcholines (n-PCSL) with the nitroxide group at 
different positions, n, in the sn-2 acyl chain, to be used for ESR experiments, 
were synthesized as described by Marsh and Watts.(25, 26) The spin-labels 
were stored at -20°C in ethanol solutions at a concentration of 1 mg/mL. 
ESR spectra of lipid and lipid/peptide samples a peptid  solution in PBS were 
recorded on a 9 GHz Bruker Elexys E-500 spectrometer (Bruker, Rheinstetten, 
Germany). Samples prepared for ESR measurements contained POPC (10 mg 
mL-1 corresponding to 1.3×10−2 M) and C8 at 0.5:1 weight ratio 
(corresponding to 0.33 molar ratio). Such a high ratio was chosen to be sure of 
the lipid bilayer saturation condition.(27) Capillaries containing the samples 
were placed in a standard 4 mm quartz sample tube containing light silicone 
oil for thermal stability. The temperature of the sample was regulated at 37 °C 
and maintained constant during the measurement by blowing thermostated 
nitrogen gas through a quartz Dewar. The instrumental settings were as 
follows: sweep width, 120 G; resolution, 1024 points; modulation frequency, 
100 kHz; modulation amplitude, 1.0 G; time constant, 20.5 ms, incident 
power, 5.0 mW. Several scans, typically 16, were accumulated to improve the 
signal-to-noise ratio. Values of the outer hyperfine splitting, 2Amax, were 
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determined by measuring, through a home-made MATLAB-based routine, the 
difference between the low-field maximum and the high-field minimum.(28) 
The main source of error on the 2Amax value is the uncertainty in composition 
of samples prepared by mixing few microliters of mother solutions. For this 
reason, reproducibility of 2Amax determination was estimated by evaluating its 
value for selected independently prepared samples with the same nominal 
composition. It was found to be ±0.4 G. 
 
2.4 Circular Dichroism Spectroscopy 
Circular Dichroism (CD) experiments were performed at 37 °C on a 810-Jasco 
spectropolarimeter, using a quartz cuvette with a path length of 1 mm. CD 
spectra of C8 were measured in PBS and in the presenc  of POPC unilamellar 
vesicles. The spectra are an average of three conseutive scans from 250 to 
200 nm, recorded with a bandwidth of 2.0 nm, a time constant of 16s, and a 
scan rate of 5 nm/min. Mean residues ellipticities, [θ]  were calculated as 
(MRW×θ)/(10×d×c). MRW=M/(n-1), where M is the molecular mass of the 
peptide and n is the number of amino acids (n-1 is the number peptide bonds). 
θ is the observed ellipticity in degrees, d is the pathlength is cm and c is the 
concentration in g mL-1. Samples prepared for CD measurements contained 
the peptide (1×10−4 M) and the phospholipid at a 10-fold higher concentration 
(1×10−3 M). During all the measurements, the trace of the high tension voltage 
was checked to be less than 700 V, which should ensur  reliability of the data 
obtained.(29) Base lines of either solvent or vesicular suspensions without 




The propensity of the peptide to assume a helical conformation was estimated 
from measurements of helical mean residue ellipticity at 222nm.(30) We used 
[θ]222 values of 0 and -40,000 (1-2.5/n) degrees cm2 dmol-1 per amino acid 
residue for 0% and 100% helicity. The correction for aromatic CD 
contributions to [θ]222 due to two internal Trp residues has been applied (
aromatic





222[ ]θ ). 
For titration experiments with surfactant molecules, CD experiments were 
carried out on a JASCO J810 spectropolarimeter at room temperature, using a 
quartz cuvette with a path length of 1 mm. CD spectra were the average of 
four accumulations from 190 to 260 nm, recorded with a band width of 1-nm, 
at a scanning speed of 10-nm/min. Base lines of either solvent or micellar 
solutions without peptide were subtracted from each respective sample to yield 
the contribution. Estimation of secondary structure content was carried out 
using the algorithms from the DICHROWEB website.(31) 
In CD experiments C8 was recorded in water and titrated with surfactant 
molecules. The CD spectra of C8 were recorded in water and in presence of 
0,6mM, 1,2mM, 5mM and 10mM of DPC and in presence of 2mM 4mM, 
8mM of SDS. Then the C8 conformational behaviour was investigated in 
mixed micelles of DPC and SDS (90:10; M/M) by dissolving the peptide in a 
DPC/SDS water mixture. 
 
2.5 Fluorescence Titration Measurements  
C8-phospholipid interactions were also studied by monitoring the changes in 
the Trp fluorescence emission spectra of the peptid upon addition of 
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increasing amounts of POPC unilamellar vescicles. Fluorescence 
measurements were performed at 37 °C using a Jasco FP750 
spectrofluorimeter, equipped with a thermostatically controlled cuvette holder. 
The excitation wavelength was 280 nm and emission spectra were recorded 
between 310 and 450 nm, with slit widths of 2 nm. 
The titration was performed by adding measured amounts of a solution 
containing the peptide (1×10−4 M) and suspended lipid vesicles to a weighed 
amount of a solution of the peptide at the same concentration, initially put into 
the spectrofluorimetric cuvette. In this way, the lipid concentration was 
progressively increased (from 0 to ~1×10−3 M), while the peptide 
concentration remained constant during the whole titration. After each 
addition there was a 20-min wait to ensure equilibrium had been reached. 
 
2.6 Molecular dynamics  
All the computer simulations reported in this study were performed using 
GROMACS 3.2 package(32) and the GROMOS96 force field. The starting 
model of C8 obtained by NMR measurements(18) was placed in a box 
containing a mixture of POPC lipids and water molecu s. After the peptide 
insertion in the box, all water molecules with oxygen atoms closer to 0.40 nm 
from a non-hydrogen atom of the peptide were removed. Initially, the peptide 
is solvated in the water phase at a distance of 7 Å from the lipid bilayer. Five-
eight simulations of 10 ps were performed, with the atomic coordinates of the 
peptide restrained to the initial positions, to equilibrate the system. This 
resulted in final systems containing 128 lipids, the C8 molecule and about 
10950 water molecules. Molecular dynamics simulations have been performed 
using the procedure described elsewhere.(33-35) Briefly, the temperature was 
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set to 310 K by coupling the system to an external bath. Bond lengths were 
constrained by the Linear Constraint Solver (LINCS) algorithm.(36) Part 
Mesh Ewald method (PME) was used for the treatment of electrostatic 
interactions for atoms at a distance greater than 9 Å. The force field and the 
coordinates for POPC were downloaded from the Tieleman group web-site 
(http://mouse.bio.ucalgary.ca) and are the same used for other works 
performed by us (33, 37) and other authors(38, 39) 
Three simulations have been performed with different initial C8 positions. The 
simulation time of the three trajectories is 70 ns. Since the analysis of the three 
trajectories showed similar results, only the features of one of the three 
trajectories are described. The lipid bilayer has been characterized by the 
analysis of membrane thickness, defined as the average phosphate-phosphate 
distance and of the density profile. Lipid tail parameters have been calculated 
with respect to the membrane normal axis. The helicity of the peptide has been 
determined by DSSP. Images have been created with Pymol 
(www.pymol.org). 
 
2.7 NMR analysis: C8 titration 
NMR spectra were recorded on a Bruker DRX-600 spectrometer. Dry peptide 
was dissolved in phosphate buffer (25mM pH 6.8). The obtained solution was 
titrated with increasing amount of surfactant (SDS, DPC) moving from 
submicelle to micelle concentration. Each step of the titration was monitored 
by one dimentional (1D) 1H homonuclear spectra. 1D 1H homonuclear spectra 
were recorded in the Fourier mode, with quadrature det ction. 
Two-dimensional (2D) spectra of the final micelle solutions were recorded. 2D 
1H homonuclear TOCSY and NOESY were run in the phase –sensitive mode 
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using quadrature detection in ω1 by time –proportional phase incrementation 
of the initial pulse.(40-42). The water signal was suppressed using 
WATERGATE pulse sequence experiments.(43).  Data block sizes were 2048 
addresses in t2 and 512 equidistant t1 values. Before Fourier transformation, 
the time domain data matrices were multiplied by shifted sin2 functions in both 
dimensions. A mixing time of 70 ms was used for the TOCSY experiments. 
NOESY experiments were run at 300 K with mixing times in the range of 100-
300 ms. Qualitative and quantitative analyses of DQF-COSY, TOCSY, and 
NOESY spectra were achieved using SPARKY software.(44) 
 
2.7.1 NMR structure calculations. 
Peak volumes were translated into upper distance bounds with the CALIBA 
routine from the CYANA software package.(45) The requisite pseudoatom 
corrections were applied for non-stereospecifically assigned protons at 
prochiral centers and for the methyl group. After discarding redundant and 
duplicated constraints, the final list of experimental constraints was used to 
generate an ensemble of 100 structures by the standard CYANA protocol of 
simulated annealing in torsion angle space implemented (using 10000 steps). 
No dihedral angle or hydrogen bond restraints were applied. The best 50 
structures that had low target function values and small residual violations 
were refined by in vacuo minimization in the AMBER 1991 force field using 
the SANDER program of the AMBER 5.0 suite.(46, 47) To mimic the effect 
of solvent screening, all net charges were reduced to 20% of their real values. 
Moreover, a distance-dependent dielectric constant (ε = r) was used. The cut-
off for non-bonded interactions was 12 Å. NMR-derivd upper bounds were 
imposed as semi-parabolic penalty functions, with force constants of 16 
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Kcal/mol Å2. The function was shifted to be linear when the violat on 
exceeded 0.5 Å. The best 10 structures after minimization had AMBER 
energies ranging from -441.4 to -391.1 Kcal/mol. Final structures were 








3.1 PEPTIDE-MEMBRANE INTERACTION 
3.1.1 Choice of solvent 
Micelle solution are made of surfactants, such as the zwitterionic dodecyl 
phosphocoline (DPC) or the negatively charged sodium dodecyl sulphate 
(SDS), at a concentration much higher than their c.m.c. These surfactants 
forms spherical aggregates where the polar head groups are located on the 
surface and the hydrophobic tail in the core. From a technical viewpoint the 
micelles are appropriate for the high-resolution liquid-state NMR studies 
because they have short rotational correlation timedue to their small size.(48, 
49). 
 
3.1.2 EPS spectroscopy 
The Electron Spin Resonance spectroscopy (ESR), by using spin-labeled 
substances (peptides and/or lipids) has been proved to give substantial 
information on the interaction between viral fusion peptides and lipid 
membranes.(20, 27, 50-53) Association of these peptides with lipid 
membranes can be detected from the perturbation of the chain mobility of 
spin-labeled lipids, as reported in the literature for membrane proteins.(54) 
ESR spectra of C8 were recorded in the presence of POPC bilayers, a 
membrane mimetic system including both a saturated (C16) and an 




Here the perturbation caused by C8 binding to POPC bilayers is investigated 
by analysing changes in the ESR spectra of spin-labeled lipids included in the 
membrane. Figure 17 shows the ESR spectra of phosphatidylcholine spin-
labeled at different positions, n in the sn-2 chain, n-PCSL, in the presence and 
absence of C8 at a peptide to lipid ratio of 0.5:1 wt/wt. In the presence of C8, 
slight but significant perturbations in the spectra of all spin-labeled lipids are 
found. 
 
Figure 17   ESR spectra of n-PCSL positional isomers of spin-labeled 
phosphatidylcholine in fluid-phase palmitoyl oleoyl phosphatidylcholine bilayer 
membranes, in the presence (solid line) and in the absence (dashed line) of 0.5:1 
wt/wt peptide 1 (C8) at 37 °C. 
 
In an attempt to quantitatively describe this behaviour, the outer hyperfine 
splitting has been evaluated. 2Amax, is a reliable and easy-to-perform estimate 
of the segmental chain mobility. 2Amax is defined as separation, expressed in 
Gauss, between the low-field maximum and the high-feld-minimum, and 
tends to increase with increasing the restriction in local chain mobility. Figure 








18 shows the dependence of the outer hyperfine splitting, 2Amax, on chain 
position, n, for the n-PCSL spin-labels in fluid POPC membranes, with and
without a saturating amount of peptide. In both cases, 2Amax decreases with 
increasing n. In the presence of C8 the characteristic flexibility gradient with 
chain position of the fluid lipid bilayer membranes is preserved, but 2Amax is 
increased at all spin-label chain positions by roughly the same extent. 
Particularly, for what concerns the spin-label presenting the nitroxide in a 
deeper position, 14-PCSL, there is no appearance of a second component in 
the spectra, corresponding to spin-labeled lipid chains whose motion is 
restricted. This is evidence that the peptide binds solely at the membrane 
surface and does not penetrate appreciably into the membrane interior, as does, 
for instance, the HIV fusion peptide gp41-FP.(55) Thus, in the case of C8, 
ESR results indicate that the decrease in lipids mobility, which is induced by 
surface association of the peptide, propagates throug out the chain region. 
 
Figure 18   Dependence on spin-label position, n, of the outer hyperfine splitting, 
2Amax, of n-PCSL in membranes of POPC, in the absence (dashed lin , solid 
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3.1.3 Fluorescence spectroscopy 
Peptide positioning relative to POPC bilayer was further investigated by 
intrinsic Trp fluorescence emission measurements. The rp emission spectra 
of C8 peptide, measured either in buffer or in the pr sence of increasing 
amounts of lipid vesicles are shown in Figure 19. C8 in water gives a Trp 
emission spectrum typical of an aqueous environment (λmax = 354 nm), 
indicating that the Trp side chains are exposed to the aqueous medium. The 
presence of POPC liposomes causes a slight blue shift of the emission 
maximum to shorter wavelength (λmax = 347 nm) and a reduction of the 
fluorescence quantum yield. The limited extent of the shift indicates that the 
Trps are greatly exposed to the solvent.(56) These results indicate that, despite 
the interaction between C8 and POPC liposomes, the Trp residues of this 































Figure 19   Fluorescence emission spectra of C8 peptide in aqueous phosphate buffer 
(A, dashed line), and in POPC unilamellar liposomes (solid line) at different lipid 




The C8 fluorescence intensities at 354 nm are plotted as a function of the lipid 
concentration in Figure 20. Fitting these data to the equation reported in the 
methods section, allows to evaluate the apparent pep ide-lipid association 
constant, Ka, and the number of phospholipid molecules, n, required to bound 
a peptide. It was obtained Ka = (8.3±0.6)×10




























Figure 20   Fluorescence titration curve of C8 peptide with phospholipid liposomes at 





3.2 Conformational analysis 
3.2.1 Circular Dichroism 
To explore the conformational modifications experimented by C8 in responce 
to the addition of surfactants in water solution, CD spectra of C8 were 
recorded in water solution (pH 6.8) and in water containing increasing 
amounts of DPC (0,6mM, 1,2mM, 5mM and 10mM) and SDS (2mM, 4mM, 
8mM) surfactants to reach ten fold critical micellar concentration for each 
surfactant.  
Quantitative evaluation of CD curves using the algorithms from the 
DICHROWEB website(31) ( CONTIN algorithm) (57) evidenced that  C8 in 
water, and in the presence of 0,6mM and 1,2 mM DPC, assumes 50% of 
random coil conformation and 50% of turn structure; addition of DPC to reach 
5mM and 10mM concentration induces modification of CD curves consistent 
with the  prevalence of C8 in α-helical structure(Figure 21). 
Analysis of CD spectra of C8 according to the algorithms from the 
DICHROWEB website(31) ( CONTIN algorithm) (57) shows that C8 moving 
from submicellar   (2mM and 4mM) to micellar concentration of SDS chances 
its conformation from randomcoil to β- turn (Figure22). 
The conformational behaviour of C8 was also investigated in mixed DPC/SDS 
(90/10 M/M) micelles. This medium was chosen as mimetic of surface charge 
found in mammalian cell membranes. The CD spectra of C8 in DPC/SDS 
micelle solution, characterized by  negative band at 218 nm and  positive band 
at 195nm (Figure 23),  according to DICHROWEB quantit tive analysis, point 






Figure 21 Circular dichroism spectra of C8 in water recorded uring the titration with 
DPC. 
 







Figure 23 Circular dichroism spectra of C8 in DPC/SDS micelle solution. 
 
 
CD spectra of C8 were recorded in the presence of POPC liposomes. In these 
conditions the spectrum assumes the double-well shape typical of a turn-






Figure 24   C8 CD spectra in aqueous phosphate buffer (dashe lin ), and in POPC 
unilamellar liposomes (solid line). T=37 °C.  
 
3.2.2 NMR analysis 
NMR spectra were recorded on a Bruker DRX-600 spectrometer. Dry peptide 
was dissolved in phosphate buffer (25mM pH 6.8). The obtained solution was 
titrated with increasing amount of surfactant (SDS, DPC) moving from 
submicellar  to ten fold micellar  concentration.  






















A water solution of C8 containing 1.5mM in 500 µl water at pH 6.8 was 
titrated with anionic (SDS) and neutral (DPC) detergent. 1D 1H NMR spectra 
were acquired at each SDS and DPC addiction.  
2D COSY, TOCSY and NOESY experiments  of C8 were acquired in SDS, 
DPC and DPC/SDS micelle solutions ( Figure 27). These spectra evidence 
clear TOCSY and NOESY correlations  to assign all proton resonances and to 
calculate reliable C8 3D models. The chemical shift assignment and the 
collection of NOE data was performed analyzing 1D and 2D TOCSY and 
NOESY spectra according to the conventional procedure of Wuthrich(58) 
Proton chemical shift of C8 in SDS, DPC and DPC/SDS micelle solution are 
reported in Tables13-15. 
The comparison of NH chemical shifts observed at each step of surfactant  
addiction shows that they are significantly perturbed y the presence of lipids. 
Figure 25  and 26 A show the chemical shift perturbation of backbone NH and 
Trp indole NH for each residue, in different micelle solutions (DPC, 
DPC/SDS, SDS). 
Moreover the proton chemical shift variations observed  during the SDS, DPC 
and DPC/SDS titrations are shown . 
When C8 is titrated with DPC NH chemical shifts aresignificantly modified in 
at 5mM and 10mM DPCconcentration. The highest variations of chemical 
shift involve the HN of Trp1, Glu2, Val5 and Gly6. 
When C8 is titrated with SDS the chemical shifts of HN show significant  
changes at 36mM and 71mM SDS concentration. The highest variations of 





Figure 25 HN chemical shift variation of C8 in different micelle solution (A) and 


















































Figure 26 HN-indole chemical shift variation of C8 in different micelle solution (A) 














































It is worth noting that the chemical shifts of Trp4 is almost constant suggesting 
a preservation of this residue from the interaction with solvent. 
 
Table 13 1H chemical shift of C8 in SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
Trp1 7.713 4.252 
 Hβ2 3.303 
Hβ3 3.142 












   
Asp3 7.770 4.476 Qβ 2.520     
Trp4 7.884 4.581 
Hβ2 3.424 
Hβ3 3.367 







Val5 7.752 3.992 2.142 
Qγ1 1.038 
Qγ2 0.995 
   
Gly6 7.966 Qα 3.900      
Trp7 7.731 4.483 
Hβ2 3.476 
Hβ3 3.399 







Ile8 7.454 3.826 1.813 
Qγ1 1.343 
Qγ2 0.995 





Table 14 1H chemical shift of C8 in DPC micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 
Trp1 8.611 4.435  Qβ 3.308    
Ηδ1 7.416 
 Ηε1 10.667 




Glu2 9.176 3.886 
Hβ2 1.999 
Ηβ3 1.941 
Qγ 2.175    
Asp3 8.046 4.505 
Hβ2 2.621 
Hβ3 2.487 
    











     
Trp7 7.635 4.449 
Hβ2 3.435 
Hβ3 3.387 

















Table 15 1H chemical shift of C8 in DPC/SDS micelle solution. 
Residue HN CαH CβH CγH CδH CεH Others 










Ηγ3  2.003 
   
Asp3 7.992 4.487   
Hβ2 2.673 
Hβ3 2.555 
    







Val5 7.952  3.894 Hβ 2.152 QQγ 0.980     
Gly6 8.100  α 3.913      







Ile8 7.556  3.644 Hβ  1.834  
Hγ12 1.468 
Hγ13 0.049  
Qγ2 0.907 






Figure 27 Fingerprint region and amide region of the NOESY spectra of C8 in SDS 






Analysis of NOESY data led to the identification of all the short interprotonic 
distances. Figure 28 contains a summary of all sequential and medium range 
connectivities relative to the NOESY spectra of C8 respectively in SDS, DPC, 
DPC/SDS micelle solutions. The diagrams show regular NN(i,i+1) and 
αN(i,i+1) NOE connectivities. C8 spectra in DPC and DPC/SDS micelle 
solutions are rich in medium range NOE connectivities whereas these effects 
are missing in the NOESY of C8 in SDS micelle soluti n.  
 
 
Figure 28 NOE connectivities of C8 in SDS (A), DPC (B), and DPC/SDS (C) micelle 
solution. 
 
The structural calculations of C8 were carried out using CYANA software on the 
basis of NOE data. This data was transformed into ierprotonic distances and 
imposed as restraints in the calculation.  
Figure 29show the calculated NMR structure bundles of C8 obtained in SDS, DPC, 
and DPC/SDS micelle solution respectively. Bundles of C8 in DPC and DPC/SDS 
micelle solution shows high structural agreement betwe n the calculated conformers 
and a common, ordered orientation of side chains (RMSD C8 in DPC:0.00 and C8 in 
A B C 
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DPC/SDS:0.00). On the contrary the structure bundle of C8 in SDS micelle solution 
is less ordered (RMSD<0.82). 
Analysis of the backbone torsion angles according to Promotif algorithm identifies 
type I β-turn conformation in Val5- Ile8 segment of C8 in DPC micelles and type I β-
turn structures in Trp1-Trp4, Glu2-Val5 and  Val5- Ile8 segments of C8 in DPC/SDS 
micelles. C8 in SDS micelle solution is characterized by a minor presence of 




Figure 29 NMR structure bundles of C8 in DPC (A), DPC/SDS (B) and SDS 




A B C 
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Figure 30 Ramachandran plot of C8 in SDS (A), DPC (B) and DPC/SDS (C) 
micelle solution 
 
3.2.3 MD simulations 
Three initial positions of the C8 structure(18) were chosen for the simulations 
to eliminate any bias due to the starting configuration. In all cases, the 
minimum distance between the peptide and the bilayer is 0.7 nm. C8 was 
attracted to the surface of the bilayer in all simulations, independent of the 





headgroups within the first nanosecond and equilibrates at the surface for the 
remainder of the simulation (up to 70 ns) (Figure 31). The secondary structure 
of the peptide drastically changes throughout the simulations. The peptide 
loses most of its starting secondary structure to become a random coil within 
the first nanosecond and subsequently it only transiently folds as a 310 helix 
with turn structures (Figure 32). At the bilayer-water interface, the structure 
was maintained throughout with 2-4 residues of the peptide being helical and 
turn structures randomly sampled. In the path taken for binding, C8 peptide 
approaches the bilayer surface without making significant contacts. Upon 
binding to membrane, strong interactions are observed between the peptide 
and the headgroups of the phospholipids.  
 
Figure 31 The minimum distance between C8 and POPC during the simulation. The 





Figure 32 Number of residues in helical conformation during the simulation. 
 
The molecular density profile and the distribution f selected atoms or 
chemical groups of the bilayer along the axis perpendicular to the membrane 
surface in presence and in the absence of the peptide is reported in Figure 33 
and Figure 34. Results are plotted relative to the center of the bilayer along the 
bilayer normal (z-axis). In particular, in Figure 33A the densities of the 
peptide and of the whole simulated system are shown, whereas in Figure 33B 
the density of Trp residues is compared with that of phosphorous atoms. The 
data in Figure 33A and 33B clearly show that the C8 is bound to the bilayer 
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reaching the headgroup region and that the Trp residu  are arranged so that 
they are facing towards the interior of the bilayer. Trp776 (numbering scheme 
of gp36) appears to be located farthest inside the POPC bilayer, while the 
other two Trp are anchored between the phosphate head groups and bulk 
water, i.e. at the water-membrane interface. 
 
Figure 33 Density profile of (A) the whole simulated system (solid lines) and of the 
C8 peptide (dashed lines) and (B) phosphorus atoms (solid line) and Trp residues 
(dashed or grey line). 
 
 
Figure 34. Density profile of the phosphorus atoms before (solid lines) and after 




The minimum distance between the Trp side chains and the POPC molecules 
as a function of time (Figure 35) reveals that at least two of the three Trp 
(Trp770 and Trp776) are ever bound to the membrane during the simulation. 
A model displaying the location of C8 on the bilayer surface, together with 
representative interactions with lipid molecules is shown in Figure 36. The 
peptide orients such that the side chains of Trp770 and 776 form hydrogen 
bonds as well as hydrophobic interactions with the lipids, and the charged Glu 
and Asp residues (Glu771 and Asp772) remain hydrogen bonded with the 
oxygens of the lipid headgroups. It has been also followed the average 
orientation of the tryptophan side-chains during the simulation to obtain a 
quantitative measure of the tryptophan ring position ng relative to the 
membrane normal. Notably, it is not observed a preference for a specific 
indole orientation with respect to the phospholipid bilayer. Indeed, indoles 
present the plane either parallel to the lipid chains or at an oblique angle to the 
membrane normal (Figure 36 B-C). No conserved hydrogen bonds between 
the peptide backbone and the headgroups of the lipid b layer are found.  
In total, during the simulations, C8 is in contact with atoms belonging to 24-30 
different POPC molecules, although, typically, the peptide binds 8-10 POPC 
molecules simultaneously. Peptide binding induces a decreasing of 0.5-1 nm2 
of solvent accessible surface for POPC oxygen and nitrogen atoms and an 
increase of 2-4 nm2 of the solvent accessible surface for POPC carbon at ms. 
Thus, the lipid headroup atoms involved in H-bonding with the peptide are 
less exposed to water molecules. At the same time, the other atoms of the 
lipids, and mainly those of their headgroups, becomes ore accessible to the 
solvent. This could be due to a decrease of local ordering, which favours water 
penetration in the headgroups domain. POPC bilayer thickness, with and 
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without the presence of C8, is reported in Table 16. By comparison of these 
values, it can be concluded that the C8 binding provokes a thinning effect of 3-
5 Å. The local reduction of the bilayer thickness induced by the peptide is 
confirmed by visual inspection of the trajectories and also suggested by Figure 
36, where the formation of a hollow on the bilayer su face can be detected. 
Figure 34 indicates that the overall density distribution of the different 
membrane component is similar in presence and in absence of the peptide, 
although a slight increase of the lipid headgroup density is observed when the 
peptide is in contact with the membrane. 
 
Figure 35 The interactions between Trp residues and POPC molecules. Green lines 
represent the minimum distance between Trp776 and POPC, black lines the distance 






Figure 36 Configuration of the system when C8 has moved to the surface of the 
bilayer (panel A). Snapshots selected from the trajectories (panel B-D). C8 is 
displayed in cyan, carbon atoms of POPC are coloured in green, oxygen atoms in red, 
nitrogen atoms in blue and phosphorous in orange, water molecules are omitted. In 
panel D, hydrogen bonds are indicated in red, hydrophobic interactions in black. 
 
Table 16  POPC bilayer properties. 
 POPC molecules 
-starting 
conformation 
POPC molecules in 
contact with C8 
before the binding 
POPC molecules in 
contact with C8 
upon the binding 
P-P thickness 
(nm) 
4.12* 4.00-4.03 (±0.02) 3.60-3.71 (±0.03) 
*The value of bilayer thickness in absence of the peptide, measured as the average 
distance between the phosphorous atoms of the upper and lower leaflets of POPC, is 





The local increase of the lipid packing density in the bilayer upon C8 binding 
reflects in the dynamics of the lipid molecules. C8 creates a local tension on 
the lipid, reducing the mobility of the lipid chains. The calculated order 
parameters of the lipids in direct contact with the peptide compared with those 
of the other lipids constituting the bilayer are reported in Figure 37A. For 
POPC molecules in contact with C8, calculated values are slightly higher in 
magnitude (indicating more order in the system), particularly for the last atoms 
of the chain. Similar results have been obtained comparing the root mean 
square deviations of POPC molecules in the presence a d in the absence of the 
peptide. Interestingly, a slightly different effect of peptide binding on the two 
monolayers is also observed. In fact, inspection of Figure 37B shows that, in 
the peptide-bound leaflet, acyl chain mobility is slightly higher close to the 




Figure 37 Calculated order parameters for POPC palmitic chains in direct contact 
with C8 (circle) and for those not in contact with the peptide (triangle) (panel A). 
Calculated order parameters for POPC palmitic chains of the leaflet in direct contact 







C8 is an octapeptide deriving from MPER domain of FIV gp36. The protein 
domain corresponding to the C8 sequence has been hypothesized to exert a 
destabilizing effect on the target-cell membrane, favouring its fusion with the 
viral envelope. The presence of three Trp residues and their spatial 
arrangement has been found to be essential to promote the C8 interaction with 
lipid membranes.(27) However, to date the experimental approaches useddo 
not have the necessary resolution to determine the a omic details of the 
interaction between the peptide and the lipids, and consequently the 
mechanism trough which the peptide originates lipid b layer perturbation 
remains unknown. In this work, we investigate the C8-lipid interactions 
combining a variety of experimental techniques with MD simulations. In 
particular, in our computations both the peptide and the lipids are considered 
at the atomistic level, thus allowing to analyze not only changes in peptide 
conformation, but also perturbations in lipid packing due to peptide-bilayer 
interaction. 
Concerning experimental data, we use: i. CD to explore the general C8 
conformational preferences in response to different membrane mimicking 
systems; ii. NMR to study the conformational behaviour of C8 in membrane 
mimicking system made up of micelle solution of SDS, DPC and DPC/SDS;  
iii. spectrofluorimetry to highlight the polarity of the microenvironment 
experienced by the Trp residues and to estimate  ths oichiometry of the 
peptide-lipid interaction, iv. ESR spectroscopy to detect perturbations in lipid 
structuring and dynamics. 
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The combined analysis of the results obtained by the different experimental 
and computational approaches techniques and MD data allows to obtain a 
complete description of the system structure and behaviour at molecular level.  
NMR and CD data show that C8 secondary structure changes moving from 
water to membrane mimicking environments represented by SDS, DPC and 
DPC/SDS micelle solution respectively. In particular this effect is significant 
in the presence of micellar concentrations of zwitterionic DPC surfactant 
where an evident modification of CD spectra is detectable, corresponding to 
the conformational transition of C8 from random coil to  turn-helical 
structures.  The conformational modification of C8  is also observable in the 
variations of NH chemical shift values measured during the titration with the 
different surfactants. Notably the titration with DPC induces selective 
modification of NH chemical shifts, as compared to a more general 
perturbation induced by SDS tensioactive.  This observation indicates that in 
DPC micellar medium  the conformational packing of C8 imposes selective 
expositions of NH protons to the solvent. The calcul tion of 3D models based 
on NMR data shows that in the three different micelle solutions C8 has a 
propensity to assume turn-helical conformations. Confirming CD data, this 
tendency  is particular evident in DPC and in  DPC/SDS mixed micelles, 
where the peptide is arranged in type I β-turn structures along all the sequence. 
NMR structures are characterized by  ordered orientation of the side chains. In 
particular  non-parallel orientation of Trp1 and Trp4 indolyl rings, form an 
“umbrella” surface  to protect the backbone of Glu3 from the contact with the 
solvent. This exposition of the side chains, accounts for the constant values of 
NH chemical shifts observed for Glu3 residue during  surfactant titration, 
moreover suggests that it may be the surface responsible for the absoption of  
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C8 on the external surface of bilayer. Fluorescence and MD results confirm 
these data, indicating that Trp residues remain exposed to the external aqueous 
medium. In particular MD data shows that Trp  form hydrogen bonds with the 
phospholipid headgroup, targeting  this residue to in erfacial region between 
water and the hydrophobic core of the bilayer, thus ampering a deep insertion 
of C8 into the membrane. MD simulations also show that the three C8 Trp 
residues are important in directing and anchoring the peptide to the membrane 
interface. We do not find a preferential orientation f the indole plane with 
respect to the membrane bilayer. But according to NMR conformational 
analysis, upon membrane binding, C8 tends to assume a turn-helical 
conformation. Because of the short peptide sequence, the secondary structure 
dynamically changes with time, nevertheless a strict interplay between peptide 
conformation and its membrane-interacting ability is observable.  
A C8 molecule interacts with an average of 6-10 lipids simultaneously. This is 
shown by both fluorescence and MD data. However simulations point out that 
a total of 24-30 different POPC molecules come in co tact with the peptide. 
The peptide affects lipids order and dynamics. The peptide effect propagates 
along the lipid acyl chain till the deep interior of the bilayer. In particular, both 
the ESR and MD data clearly show that the presence of the peptide induces a 
reduction of the segmental acyl chain mobility for n ≥ 5-8.  As a result of the 
peptide adsorption, a local reduction of the bilayer thickness by 2-5 Å is 
detected. In more details, MD results specify that the peptide adsorption 
perturbs the lipid packing and mobility in the bilayer leaflet in direct contact 
with the peptide, the opposite one being less perturbed. This marked 
asymmetry of the bilayer originates a sort of invagin tion, as well detectable in 
the MD simulation shown in Fig. 36A. Thus our result  definitely highlight 
99 
 
that changes in the POPC microstructuring due to the C8 interaction reflect on 






The experimental strategy set up for this study, has proved to be extremely 
informative of the miscrostructure and dynamics of c mplex systems such as 
lipid membranes interacting with peptides/proteins. Particularly, MD 
simulations have been found to be a valuable tool t rationalize all the 
experimental results obtained by NMR, CD, ESR and fluorescence 
spectroscopy. The findings of the present work could help in shedding light on 
the mechanism through which viral glycoproteins help to overcome the 
energetic barrier inherent with the fusion between the target cell plasma 
membrane and the viral envelope, and particularly on the role played by the 
MPER protein domain in the process. Our data suggest that lipid bilayer 
destabilization could be a consequence of the asymmetric perturbation of the 
bilayer that starts with an increased hydration of lipid headgroups coupled to 
an increase of lipid ordering in the leaflet exposed to the approaching viral 
glycoprotein. In particular, since water organization at membrane interface has 
been proposed to control the fusion dynamics, the increment of bilayer 
hydration could be a fundamental part of role played by the MPER fusion 
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